<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
<journal-id journal-id-type="publisher-id">ijms</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">1422-0067</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32707661</article-id>
<article-id pub-id-type="pmc">7404093</article-id>
<article-id pub-id-type="doi">10.3390/ijms21145094</article-id>
<article-id pub-id-type="publisher-id">ijms-21-05094</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The COVID-19 Pandemic: Does Our Early Life Environment, Life Trajectory and Socioeconomic Status Determine Disease Susceptibility and Severity?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Holuka</surname>
<given-names>Cyrielle</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-21-05094">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Merz</surname>
<given-names>Myriam P.</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-21-05094">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fernandes</surname>
<given-names>Sara B.</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-21-05094">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Charalambous</surname>
<given-names>Eleftheria G.</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-21-05094">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9297-4616</contrib-id>
<name>
<surname>Seal</surname>
<given-names>Snehaa V.</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-21-05094">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Grova</surname>
<given-names>Nathalie</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-21-05094">1</xref>
<xref ref-type="aff" rid="af2-ijms-21-05094">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2760-1071</contrib-id>
<name>
<surname>Turner</surname>
<given-names>Jonathan D.</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-21-05094">1</xref>
<xref ref-type="corresp" rid="c1-ijms-21-05094">*</xref>
</contrib>
</contrib-group>
<aff id="af1-ijms-21-05094"><label>1</label>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg; <email>cyrielle.holuka@lih.lu</email> (C.H.); <email>myriam.merz@lih.lu</email> (M.P.M.); <email>SaraBeatriz.Fernandes@lih.lu</email> (S.B.F.); <email>eleftheria.charalambous@lih.lu</email> (E.G.C.); <email>snehaa.seal@lih.lu</email> (S.V.S.); <email>nathalie.grova@lih.lu</email> (N.G.)</aff>
<aff id="af2-ijms-21-05094"><label>2</label>Calbinotox, Faculty of Science and Technology, Lorraine University, 54506 Nancy, France</aff>
<author-notes>
<corresp id="c1-ijms-21-05094"><label>*</label>Correspondence: <email>jonathan.turner@lih.lu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>7</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<month>7</month>
<year>2020</year>
</pub-date>
<volume>21</volume>
<issue>14</issue>
<elocation-id>5094</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>6</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>7</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Â© 2020 by the authors.</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>A poor socioeconomic environment and social adversity are fundamental determinants of human life span, well-being and health. Previous influenza pandemics showed that socioeconomic factors may determine both disease detection rates and overall outcomes, and preliminary data from the ongoing coronavirus disease (COVID-19) pandemic suggests that this is still true. Over the past years it has become clear that early-life adversity (ELA) plays a critical role biasing the immune system towards a pro-inflammatory and senescent phenotype many years later. Cytotoxic T-lymphocytes (CTL) appear to be particularly sensitive to the early life social environment. As we understand more about the immune response to SARS-CoV-2 it appears that a functional CTL (CD8+) response is required to clear the infection and COVID-19 severity is increased as the CD8+ response becomes somehow diminished or exhausted. This raises the hypothesis that the ELA-induced pro-inflammatory and senescent phenotype may play a role in determining the clinical course of COVID-19, and the convergence of ELA-induced senescence and COVID-19 induced exhaustion represents the worst-case scenario with the least effective T-cell response. If the correct data is collected, it may be possible to separate the early life elements that have made people particularly vulnerable to COVID-19 many years later. This will, naturally, then help us identify those that are most at risk from developing the severest forms of COVID-19. In order to do this, we need to recognize socioeconomic and early-life factors as genuine medically and clinically relevant data that urgently need to be collected. Finally, many biological samples have been collected in the ongoing studies. The mechanisms linking the early life environment with a defined later-life phenotype are starting to be elucidated, and perhaps hold the key to understanding inequalities and differences in the severity of COVID-19.</p>
</abstract>
<kwd-group>
<kwd>COVID-19</kwd>
<kwd>SARS-CoV-2</kwd>
<kwd>socioeconomic status</kwd>
<kwd>early life adversity</kwd>
<kwd>psychosocial stress</kwd>
<kwd>immunosenescence</kwd>
<kwd>immune exhaustion</kwd>
<kwd>health inequalities</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-ijms-21-05094" sec-type="intro">
<title>1. Introduction</title>
<p>The ongoing outbreak of coronavirus disease (COVID-19) was first reported in December 2019 in Wuhan, China. COVID-19 is caused by a betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that affects the respiratory system [<xref ref-type="bibr" rid="B1-ijms-21-05094">1</xref>]. Despite draconian sanitary measures being applied worldwide, COVID-19 was declared a pandemic on 11 March 2020 by The World Health of Organization (WHO) [<xref ref-type="bibr" rid="B2-ijms-21-05094">2</xref>]. By May 13th the outbreak had infected over 4 million people and caused almost 300,000 deaths worldwide (World Health of Organization, 2020).</p>
<p>There is a long-established epidemiological observation that social adversity associates with reduced host resistance to infection and disease [<xref ref-type="bibr" rid="B3-ijms-21-05094">3</xref>] which goes back as far as 1976 [<xref ref-type="bibr" rid="B4-ijms-21-05094">4</xref>]. More recently, it was recognized that the effect on adult immune function and disease risk was much stronger when the exposure to adversity occurred during early life [<xref ref-type="bibr" rid="B5-ijms-21-05094">5</xref>,<xref ref-type="bibr" rid="B6-ijms-21-05094">6</xref>]. Humans are not fully developed at birth. Nervous and immune systems are gradually developed and educated up to the age of two. In fact, human life commences and develops for the first 1000 days starting from fetal conception. Any pre-natal complications and post-natal adversity faced defines the lifelong health trajectory [<xref ref-type="bibr" rid="B7-ijms-21-05094">7</xref>]. As the COVID-19 pandemic has progressed, it has become clear there are many inequalities in susceptibility and severity of the disease. The recent flurry of pre-print clinical data from many countries worldwide including China, UK, US, are strongly concordant; the lower the current socioeconomic status (SES), the greater the risk [<xref ref-type="bibr" rid="B8-ijms-21-05094">8</xref>], however, the role of the early life period and the resultant life-course has so far not been investigated. To understand the mechanisms underlying these differences, we need to dissect the exposome and environmental factors (i.e., pollutants, stress situation, etc.) that patients may be, or have previously been exposed to.</p>
<p>There is a well-established literature on the role of the overall trajectory from early life through to adulthood and the risk of non-communicable diseases such as cardiovascular disease, diabetes, obesity and depression [<xref ref-type="bibr" rid="B9-ijms-21-05094">9</xref>], however there is no data on how it affects COVID-19. Although current SES has been associated with the risk, progression and even survival of non-communicable diseases [<xref ref-type="bibr" rid="B10-ijms-21-05094">10</xref>], it is now becoming clear that during an individualâs life there are periods of increased susceptibility, and the overall trajectory of SES may be more important. This has led to the âBarker theoryâ, or the Developmental Origins of Health and Disease (DOHaD) [<xref ref-type="bibr" rid="B11-ijms-21-05094">11</xref>]. In addition, environmental influences which act during early development/life may determine our susceptibility to the disease many years later [<xref ref-type="bibr" rid="B11-ijms-21-05094">11</xref>,<xref ref-type="bibr" rid="B12-ijms-21-05094">12</xref>,<xref ref-type="bibr" rid="B13-ijms-21-05094">13</xref>].</p>
<p>Over time, the Barker theory has been refined. Currently, this is thought of as a âthree hit modelâ. The three âhitsâ are generally accepted as: (1) genetic predisposition, (2) early life environment and, (3) later life environment [<xref ref-type="bibr" rid="B14-ijms-21-05094">14</xref>,<xref ref-type="bibr" rid="B15-ijms-21-05094">15</xref>]. As high-quality mechanistic studies have addressed the link between the early-life period and adult disease, it is becoming clear that the immune system, particularly through chronic low-grade inflammation and accelerated immuno-senescence is, mechanistically, in the heat of the action. In addition, we know that stressful experiences during early life induce adaptive responses that are often mediated by the immune system [<xref ref-type="bibr" rid="B16-ijms-21-05094">16</xref>].</p>
<p>In this manuscript, we examine the data linking early life adversity to life-long disturbances in the immune system that may play a role in determining its ability to fight SARS-CoV-2 infection, potentially determining the severity of COVID-19 disease and expanding DOHaD to cover infectious diseases later in life.</p>
<p>Furthermore, we review known factors of ELA and their potential influence on the adult immune system and contemplate what kind of data should be collected to understand how SES and ELA influence disease susceptibility and severity of COVID-19 and other diseases. We hope this work will contribute in protecting and treating people at risk of developing severe COVID-19 symptom.</p>
</sec>
<sec id="sec2-ijms-21-05094">
<title>2. The Role of Current SES in COVID-19 Morbidity and Mortality</title>
<p>Socioeconomic status (SES) or gradient is a combination of education, incomes, occupation and reveal inequities to privileges or resources between individuals [<xref ref-type="bibr" rid="B10-ijms-21-05094">10</xref>]. Indeed, socioeconomic factors (i.e., race/ethnicity) are considered as fundamental determinants in human life span, well-being and health [<xref ref-type="bibr" rid="B10-ijms-21-05094">10</xref>]. Data from influenza pandemics of 1918 and 2009 showed that socioeconomic factors may determine both disease detection rates and overall outcomes [<xref ref-type="bibr" rid="B17-ijms-21-05094">17</xref>,<xref ref-type="bibr" rid="B18-ijms-21-05094">18</xref>,<xref ref-type="bibr" rid="B19-ijms-21-05094">19</xref>]. In the early phase of the COVID-19 pandemic many studies focused on basic criteria (i.e., age, sex, and gender) to investigate coronavirus spread, transmission routes and potential high-risk populations. Socioeconomic data were, unfortunately, missing as they are not considered as data of clinical interest [<xref ref-type="bibr" rid="B16-ijms-21-05094">16</xref>]. However, socioeconomic data regroup many relevant factors as daily situations (i.e., stressful job, pollution, etc.) that directly interact with human health [<xref ref-type="bibr" rid="B16-ijms-21-05094">16</xref>]. Evidence is now starting to emerge that COVID-19 mortality is increased in ethnic minority populations. US data indicates that, for example, in Chicago approximately 70% of the deaths were from ethnic minorities [<xref ref-type="bibr" rid="B20-ijms-21-05094">20</xref>]. Detailed data from New York showed that the number of COVID-19 cases associated with the percentage of dependents in the local population, the male:female ratio, and low-income neighborhoods [<xref ref-type="bibr" rid="B21-ijms-21-05094">21</xref>]. United States-wide data gave a similar result, with proportion of residents &gt;65 years old, ethnic minorities, male:females ratio, and the overall population density associating with increased frequency of COVID-19 [<xref ref-type="bibr" rid="B22-ijms-21-05094">22</xref>]. The United Kingdom followed a similar profile. Although the recent UK data only looked at mortality, there was a stronger link between COVID-19 mortality and SES than ethnic background. A 1% increase in the lower socioeconomic class increased COVID-19 mortality by 2% (95% Confidence interval of 1% to 4%) while a 1% increase in ethnic minority increase mortality by only 1% (95% confidence interval 1% to 2%) [<xref ref-type="bibr" rid="B8-ijms-21-05094">8</xref>]. Although these are preliminary (pre-print) data, they agree with Shi et al., who reported that the most severe cases were mostly agricultural laborers [<xref ref-type="bibr" rid="B23-ijms-21-05094">23</xref>]. The link between the incidence of COVID-19 and lower income neighborhoods and lower SES is most likely due to the overall economic conditions such as poverty, performing essential public tasks, poor quality and over-populated housing as well as an obligation to use public transport [<xref ref-type="bibr" rid="B8-ijms-21-05094">8</xref>] as well as higher rates of known comorbidities including type 1 and 2 diabetes, as well as cardiovascular disease and hypertension [<xref ref-type="bibr" rid="B24-ijms-21-05094">24</xref>]. Overall, despite the scarcity of the data, we interpret what is available as a suggestion that current SES and neighborhood influence the morbidity of SARS-CoV-2 infection and COVID disease rather than the mortality rate.</p>
</sec>
<sec id="sec3-ijms-21-05094">
<title>3. The Role of Early Life in Determining Lifelong Health Trajectories</title>
<p>When considering the early-life environment, many measures such as SES are broad and encompass many concurrent elements. We have previously found it useful to separate these into four principal sub-categories [<xref ref-type="bibr" rid="B15-ijms-21-05094">15</xref>] (<xref ref-type="fig" rid="ijms-21-05094-f001">Figure 1</xref>). Although determining the contribution of each of the four elements (psychosocial stress, infection, nutrition and microbiome, and pollutant exposure) is difficult, there are data on well-defined exposure conditions that fit into these sub-categories as well as insidious, general measures like SES.</p>
<sec id="sec3dot1-ijms-21-05094">
<title>3.1. Early Life Psychosocial Stress</title>
<p>There is now a growing literature on the effects of early-life psychosocial adversity on the immune system. We have previously reported the immunophenotype of young adults that had experienced ELA as institutionalization after separation from their parents and subsequently adopted in early childhood compared to those reared by their biological parents (EpiPath cohort) [<xref ref-type="bibr" rid="B25-ijms-21-05094">25</xref>]. In this cohort, we surveyed the innate, humoral, and adaptive immune system. We observed an increase in activated and senescent pro-inflammatory T cells, particularly those, expressing HLA-DR/CD25 and CD5. Senescence is a natural aging process affecting all cells including immune cells. These begin to deteriorate and this leads to weakened immune responses [<xref ref-type="bibr" rid="B26-ijms-21-05094">26</xref>]. Furthermore, there was a trend toward an increase in the number of circulating Th17 cells [<xref ref-type="bibr" rid="B27-ijms-21-05094">27</xref>,<xref ref-type="bibr" rid="B28-ijms-21-05094">28</xref>]. ELA clearly accelerated T-lymphocyte maturation and senescence, although did not affect B cells. T- lymphocytes were accelerated through their maturation cycle from naÃ¯ve to effector memory and aggregating in the terminally differentiated effector memory cells re-expressing CD45RA (TEMRA) cell phase [<xref ref-type="bibr" rid="B27-ijms-21-05094">27</xref>,<xref ref-type="bibr" rid="B28-ijms-21-05094">28</xref>]. This skewing of the immune system, in particular the cytotoxic CD8+ T-cells was confirmed in an independent cohort, of teenagers approximately 15 years after a similar form of ELA [<xref ref-type="bibr" rid="B29-ijms-21-05094">29</xref>].</p>
<p>Telomere length decreases with chronological and biological age, after cell division, and is a hallmark of cellular senescence. Exposure to stressful events during childhood showed that the telomere length is shorter in these individuals when compared to the control group [<xref ref-type="bibr" rid="B30-ijms-21-05094">30</xref>,<xref ref-type="bibr" rid="B31-ijms-21-05094">31</xref>,<xref ref-type="bibr" rid="B32-ijms-21-05094">32</xref>,<xref ref-type="bibr" rid="B33-ijms-21-05094">33</xref>], confirming that ELA negatively contributes to an imbalanced immune system [<xref ref-type="bibr" rid="B34-ijms-21-05094">34</xref>]. Furthermore, Cohen et al. showed that low childhood SES significantly decreased the telomere length later in life of a CD8+CD28- T cell population, which play major role in the response to viral infections [<xref ref-type="bibr" rid="B35-ijms-21-05094">35</xref>].</p>
<p>Studies with rodents produced the predominant hypothesis that the mechanism by which ELA impacts the function of CD8+ cells and, consequently, viral responses, may be through the HPA axis. ELA negatively impacts the HPA axis, which programs its effects and responses later in life. This normally results in a decreased release of corticosterone or cortisol after exposure to stress which consequently has a great impact on the peripheral immune system, leading to compromised viral responses [<xref ref-type="bibr" rid="B36-ijms-21-05094">36</xref>,<xref ref-type="bibr" rid="B37-ijms-21-05094">37</xref>,<xref ref-type="bibr" rid="B38-ijms-21-05094">38</xref>,<xref ref-type="bibr" rid="B39-ijms-21-05094">39</xref>]. However, results from mechanistic studies in our EpiPath cohort have excluded this. We were able to show that despite an altered HPA axis [<xref ref-type="bibr" rid="B25-ijms-21-05094">25</xref>], glucocorticoid signaling and the peripheral HPA-axis stress system were not epigenetically programed [<xref ref-type="bibr" rid="B40-ijms-21-05094">40</xref>], implying that the immune system was directly impacted.</p>
</sec>
<sec id="sec3dot2-ijms-21-05094">
<title>3.2. Early Life-Infections</title>
<p>It is well known that an early life exposure to infection and inflammation can have devastating effects. One example would be that neonates suffering from bacterial or viral sepsis are about threefold more likely to die within the first 120 days [<xref ref-type="bibr" rid="B41-ijms-21-05094">41</xref>]. There is also evidence showing that sepsis in new-borns was associated with poor long-term neurodevelopment [<xref ref-type="bibr" rid="B42-ijms-21-05094">42</xref>]. The immediate risk of infection to the organism, especially for those more vulnerable, seems obvious. The long-term consequences of an infection prove far more difficult to grasp.</p>
<p>Bilbo and Schwarz reviewed available data on the connection between perinatal infection and long-term effects on stress reactivity and cytokine production [<xref ref-type="bibr" rid="B43-ijms-21-05094">43</xref>] showing that early life infection leads to a cytokine storm (the most prominent being interleukin 1Î² [IL-1Î²], IL-6 and tumor necrosis factor Î± [TNFÎ±] which can pass the blood-brain-barrier and cause long term memory impairment in the hippocampus. Similarly, we found a blunted response to stress and a higher number of exhausted T-lymphocytes in our EpiPath adoptee cohort, which had a higher incidence of cytomegalovirus (CMV) infection and an overall higher risk of childhood infections due to the institutionalization [<xref ref-type="bibr" rid="B25-ijms-21-05094">25</xref>,<xref ref-type="bibr" rid="B27-ijms-21-05094">27</xref>]. A very recent study in zebrafish shows that expression of several pro-inflammatory genes is increased in adult fish after early life bacterial infection [<xref ref-type="bibr" rid="B44-ijms-21-05094">44</xref>]. This study also showed that the age of the first infection is a crucial factor for the adult immune response. Other studies have specifically linked early-life respiratory viral infection with a higher likelihood to develop diseases like childhood asthma or allergies [<xref ref-type="bibr" rid="B45-ijms-21-05094">45</xref>,<xref ref-type="bibr" rid="B46-ijms-21-05094">46</xref>,<xref ref-type="bibr" rid="B47-ijms-21-05094">47</xref>] or the chance to develop type 1 diabetes [<xref ref-type="bibr" rid="B48-ijms-21-05094">48</xref>]. These chronic conditions are known risk factors for a more severe outcome of COVID-19 disease.</p>
<p>Currently, the molecular mechanisms in which an early life infection distorts the immune system are only partially understood. In in-vitro experiments, Fonseca et al. demonstrated that early-life exposure to bacteria in combination with respiratory syncytial virus (RSV) later in life can lead to epigenetic modifications impacting bone marrow progenitor cells and therefore causing long-term re-shaping of inflammatory mediators and metabolic profiles [<xref ref-type="bibr" rid="B49-ijms-21-05094">49</xref>]. Subsequently, all daughter cells of these progenitors would be ill-equipped to handle subsequent infections [<xref ref-type="bibr" rid="B47-ijms-21-05094">47</xref>].</p>
<p>Certainly, early life infections present a specific type of early life adversity. It is indubitably linked to the overall health of the individual (immune system) and the social environment, given that host-to-host transmission of pathogens are by far the most prevalent form of infection. In the previous section, we showed the impact of psychosocial stress on the immune system. However, the overlap does not end there: sickness, in humans and animals, also changes their social behavior. Well known behavioral changes include a decrease in activity and expanded sleeping periods [<xref ref-type="bibr" rid="B50-ijms-21-05094">50</xref>]. Therefore, social behavior and infection should not be treated as two distinct adversities, but as two sides of the same coin.</p>
<p><italic>Early life nutrition and the microbiome</italic>: Over the last decade it has become clear that once the microbiome is established it is shaped by the exposome and the ~9 million microbial genes it encodes and play a crucial role in determining host development and health [<xref ref-type="bibr" rid="B14-ijms-21-05094">14</xref>,<xref ref-type="bibr" rid="B51-ijms-21-05094">51</xref>,<xref ref-type="bibr" rid="B52-ijms-21-05094">52</xref>,<xref ref-type="bibr" rid="B53-ijms-21-05094">53</xref>]. Modulating the host most probably protects the natural enteric symbiotic microbial community, and disturbing the established microbiome, producing a dysbiosis, results in disease and may even be fatal [<xref ref-type="bibr" rid="B54-ijms-21-05094">54</xref>,<xref ref-type="bibr" rid="B55-ijms-21-05094">55</xref>]. The microbiome established is dependent on the route of birth, and is then modulated by nutritional intake, living conditions, the polluted environment and the presence of pets [<xref ref-type="bibr" rid="B56-ijms-21-05094">56</xref>,<xref ref-type="bibr" rid="B57-ijms-21-05094">57</xref>]. As SARS-CoV-2 appears to persist in the GI tracts and can be detected in human feces [<xref ref-type="bibr" rid="B58-ijms-21-05094">58</xref>,<xref ref-type="bibr" rid="B59-ijms-21-05094">59</xref>], it will interact, affect, and be affected by the microbiome. Indeed, diarrhea is now recognized by the Centers for Disease Control and Prevention (CDC) as a COVID-19 symptom and it is a clear sign of microbial dysbiosis [<xref ref-type="bibr" rid="B60-ijms-21-05094">60</xref>]. The interaction and effects of SARS-CoV-2 will almost certainly depend on both the microbiome that has been established and how the host has adapted to its microbiome.</p>
<p>The LPS content and immunostimulatory potential of the initial early-life microbiome depends on the birth route [<xref ref-type="bibr" rid="B51-ijms-21-05094">51</xref>]. The microbiome is established during a sensitive period in which the new-born immune system is primed [<xref ref-type="bibr" rid="B61-ijms-21-05094">61</xref>], and may explain why babies born by caesarean section have a significantly increased risk of allergy or asthma later in life [<xref ref-type="bibr" rid="B62-ijms-21-05094">62</xref>]. Exposure of new-borns to a more diverse microbiota soon after birth altered both the disease susceptibility and maturation of specific immune cell subsets, whereas if the first encounter occurred later, immune dysfunction was not corrected [<xref ref-type="bibr" rid="B63-ijms-21-05094">63</xref>,<xref ref-type="bibr" rid="B64-ijms-21-05094">64</xref>]. Regulatory T cells (T<sub>reg</sub>) play a significant role in the host adaptation to the microbiome, recognize host-specific commensal bacteria derived antigens [<xref ref-type="bibr" rid="B65-ijms-21-05094">65</xref>], and result in long-term tolerance to the enteric microbiome [<xref ref-type="bibr" rid="B66-ijms-21-05094">66</xref>]. It would appear that adverse microbiota is essential for the immune system to fully mature [<xref ref-type="bibr" rid="B67-ijms-21-05094">67</xref>].</p>
<p>Peri-natal viral infections, such as CMV have been extensively studied and linked to lifelong changes in the microbiome [<xref ref-type="bibr" rid="B68-ijms-21-05094">68</xref>] and common viruses such as influenza are known to affect the development of the immune system when acquired at birth and during infancy [<xref ref-type="bibr" rid="B69-ijms-21-05094">69</xref>]. The angiotensin-converting enzyme 2 (ACE2) receptor may play a role in determining microbiome-immune-interactions. In the GI tract ACE2 is expressed in enterocytes and is important for maintaining both antimicrobial peptide expression, and the overall health of the microbiome [<xref ref-type="bibr" rid="B70-ijms-21-05094">70</xref>,<xref ref-type="bibr" rid="B71-ijms-21-05094">71</xref>]. Mice lacking Ace2 develop gut absorption related diseases [<xref ref-type="bibr" rid="B70-ijms-21-05094">70</xref>,<xref ref-type="bibr" rid="B72-ijms-21-05094">72</xref>]. As Sars-Cov-2 uses ACE2 receptor to enter cells [<xref ref-type="bibr" rid="B73-ijms-21-05094">73</xref>,<xref ref-type="bibr" rid="B74-ijms-21-05094">74</xref>] it would be logical to assume that there is a link between the virus and the microbiome that was established in early life, immune cells resident in the GI tract and the overall outcome of COVID-19.</p>
<p><italic>Early life-pollution exposure</italic>: There is emerging evidence that environmental exposure to pollutants during sensitive developmental periods like early life could be a strong factor of susceptibility, predisposing the individual to birth outcomes and disease onset in later life [<xref ref-type="bibr" rid="B15-ijms-21-05094">15</xref>]. Prenatal exposure to airborne pollutants could affect fetal reprograming by epigenetic modifications (e.g., DNA methylation) and may therefore explain the potential link between air pollutant exposure and adverse pregnancy outcomes. Epidemiological studies have pointed out causal association between fine particulate matter (2.5 Î¼m; PM2.5) and neurodevelopmental (ADHD, autism)/neurodegenerative (Parkinsons, Alzheimers) [<xref ref-type="bibr" rid="B15-ijms-21-05094">15</xref>], metabolic, cardiovascular [<xref ref-type="bibr" rid="B75-ijms-21-05094">75</xref>] and lung pathologies [<xref ref-type="bibr" rid="B76-ijms-21-05094">76</xref>]. Air pollutants were therefore proved to affect key cellular/molecular targets during the perinatal period, which are susceptible to alter immune responses link to abnormal respiratory functions and lung diseases later in life [<xref ref-type="bibr" rid="B77-ijms-21-05094">77</xref>]. For instance the EDEN birth cohort study, focusing on determining peri-natal factors that influence childhood health and social development, pointed out that a pre-natal exposure to PM10 (particles with diameter less than 10 Âµm) was linked to an increased in CD8+ T cell and a decreased in regulatory T cells in infants at birth, leading to a potential increase in the susceptibility of viral infection responses as well as atopy development in children [<xref ref-type="bibr" rid="B78-ijms-21-05094">78</xref>]. The impact of traffic pollutants and tobacco smoke on regulation of numerous Immune related-genes, such as cytokines (e.g., IL-4, IL-6, and IFNg), TLR2, nitric oxide synthases (NOSs), and several factors of transcription (e.g., Runx3 and Foxp3), has also been demonstrated [<xref ref-type="bibr" rid="B77-ijms-21-05094">77</xref>]. It is now well established that modifications in DNA methylation patterns due to PM 2.5 exposure are frequently associated with the development of lung pathologies [<xref ref-type="bibr" rid="B79-ijms-21-05094">79</xref>]. However, it remains difficult to assess whether exposure during early life has a stronger impact on development of diseases than that of the adulthood, or whether substantial morbidity is the result of accumulated exposure [<xref ref-type="bibr" rid="B76-ijms-21-05094">76</xref>].</p>
<p>In the context of COVID-19, Zhu et al. demonstrated significant associations between air pollution and COVID-19 infection. High concentration levels of PM<sub>2.5</sub>, PM<sub>10</sub>, CO, NO<sub>2</sub> and O<sub>3</sub> were therefore positively linked to a risk of COVID-19 infection, whereas high concentration levels of SO<sub>2</sub> were negatively linked to the number of daily COVID-19 confirmed cases [<xref ref-type="bibr" rid="B80-ijms-21-05094">80</xref>]. These results are supported by those obtained in February 2020 by Martelletti et al., who showed that in the industrialized regions of Northern Italy, those most affected by COVID-19, the concentration levels of PM10 and PM2.5 were above the legislative standard limit of 50 Î¼g per day [<xref ref-type="bibr" rid="B81-ijms-21-05094">81</xref>]. The adsorption of SARS-CoV-2 RNA on airborne PM (PM2.5 and PM10) was established in these regions by Setti et al. who suggested that, âin conditions of atmospheric stability and high concentration of PM, SARS-CoV-2 could create clusters with outdoor PM, and, by reducing their diffusion coefficient, enhance the persistence of the virus in the atmosphere.â [<xref ref-type="bibr" rid="B82-ijms-21-05094">82</xref>]. In a cross-sectional observational study conducted in the United States, Wu et al. showed, by taking into account 20 potential confounding factors in their main analysis, that a slight increase in PM2.5 (+1 Î¼g/m<sup>3</sup>) was linked to an 8% increase in the rate of COVID-19 death [<xref ref-type="bibr" rid="B83-ijms-21-05094">83</xref>]. Although all this data results from preliminary investigations, it tends to suggest a positive relationship between ambient air pollution exposure and COVID-19 mortality rate. Confirming the direct impact of airborne pollutants on the COVID-19 severity could prove an asset in terms of public health and prevention strategy in places with poor air quality.</p>
<p>We have previously highlighted the role of early-life pollution exposure and a potential âsecond hitâ in the âthree-hitâ model producing a quiescent phenotype, likely encoded in the epigenome, which might become vulnerable in later life to a âthird environmental hitâ such as COVID-19 [<xref ref-type="bibr" rid="B15-ijms-21-05094">15</xref>]. Given the long-term effects on health of early-life pollutant exposure and the linkage with the development and progression of pulmonary pathologies in later-life, it is reasonable to assume that early-life pollutant exposure will affects the course of COVID-19.</p>
</sec>
</sec>
<sec id="sec4-ijms-21-05094">
<title>4. Early Life Origins of COVID Co-Morbidities</title>
<p>If the early life environment plays a role in determining the outcome of COVID-19, examining its role in the key comorbidities is essential. The three key comorbidities determining COVID-19 severity are cardiovascular disease, hypertension and diabetes. The seminal work of David Barker clearly identified the role of the in-utero environment, another source of early life adversity, in determining the risk of both cardiovascular disease and hypertension. While this has been extensively reviewed elsewhere [<xref ref-type="bibr" rid="B84-ijms-21-05094">84</xref>,<xref ref-type="bibr" rid="B85-ijms-21-05094">85</xref>,<xref ref-type="bibr" rid="B86-ijms-21-05094">86</xref>] it is worth noting that the relative risk associated with birthweight and ponderal index is by far larger than any other risk factor identified for either disease to date. There is now a large body of evidence showing diabetes to be a major risk of complications and death after SARS-CoV-2 infection [<xref ref-type="bibr" rid="B87-ijms-21-05094">87</xref>], as in previous coronavirus outbreaks [<xref ref-type="bibr" rid="B88-ijms-21-05094">88</xref>], while the risk of SARS-CoV-2 infection appears to be similar [<xref ref-type="bibr" rid="B89-ijms-21-05094">89</xref>]. Like the other elements discussed here, type 2 diabetes (T2D) may have its origins in early life. There are well-established, classical risk factors that contribute to T2D including obesity, age, stress, inflammation, diet, lifestyle and environment (both early and late life), however there is growing recognition for non-classical factors such as pollution, exposure to ionizing radiations and low socio-economic status (SES). The classical and non-classical factors are intimately intertwined. SES is a broad measure encompassing prior life history, and low SES also increases the risk for obesity, stress, environmental and lifestyle factors (BMI, smoking, alcoholâ¦) as well as a pro-inflammatory phenotype [<xref ref-type="bibr" rid="B90-ijms-21-05094">90</xref>].</p>
<p>The importance of T2D in determining COVID-19 severity may in part be due to treatment strategies currently used in T2D together with another severe co-morbidity, hypertension. Both are often treated with ACE (angiotensin converting enzyme) inhibitors and ARBs (angiotensin II receptor blockers). These increases ACE2 (angiotensin converting enzyme 2) expression in pancreatic islets, lungs, intestines, etc. [<xref ref-type="bibr" rid="B91-ijms-21-05094">91</xref>]. SARS-CoV-2 exploits these ACE2 receptors to enter host cells, thus potentially increasing the risk of infection in T2D patients [<xref ref-type="bibr" rid="B92-ijms-21-05094">92</xref>]. Increased pancreatic ACE2 activation has been reported to inflict beta cell damage complicating the prognosis [<xref ref-type="bibr" rid="B93-ijms-21-05094">93</xref>] and further contributing to the characteristic âcytokine stormâ observed in COVID-19 cases. Other T2D drugs that induce ACE2 expression include pioglitazone, liraglutide, gliflozins, and DPP4 (dipeptidyl peptidase 4) inhibitors and have also been implied to promote coronavirus predisposition [<xref ref-type="bibr" rid="B94-ijms-21-05094">94</xref>]. This may be further accentuated by hyperglycemia-induced ACE2 glycosylation. ACE2 glycosylation is also a prerequisite for the virus to latch onto the ACE2 receptors [<xref ref-type="bibr" rid="B95-ijms-21-05094">95</xref>]. This enhancement is reversible by strict glycemic control [<xref ref-type="bibr" rid="B95-ijms-21-05094">95</xref>]. As such, glycemic and overall diabetic status have been proposed as predictors of COVID-19 severity and mortality [<xref ref-type="bibr" rid="B96-ijms-21-05094">96</xref>].</p>
<p>Although current T2D status may play an important role in SARS-CoV-2 susceptibility and COVID-19 severity, it is part of a larger etiopathological risk complex. T2D may have its origins in the early life social environment. Low early-life SES showed a clear, strong, association with individual metabolic profiles that was not true for current SES [<xref ref-type="bibr" rid="B97-ijms-21-05094">97</xref>]. This result has been replicated by another study that highlighted the effect of SES during adolescence on the development of T2D up to fifty years later [<xref ref-type="bibr" rid="B98-ijms-21-05094">98</xref>]. More recently, Chandan et al. (2020) reported a retrospective population-based cohort of 80,657 adults that had been exposed to ELA and 161,314 unexposed controls. This seminal study clearly demonstrated the link between childhood maltreatment and cardiovascular disease, hypertension, and T2D. In a population where ELA rates may reach 25%, their data clearly shows that âa significant proportion of the cardiometabolic and diabetic disease burden may be attributable to maltreatmentâ [<xref ref-type="bibr" rid="B99-ijms-21-05094">99</xref>].</p>
<p>There is now some mechanistic evidence to back up the link between ELA and T2D. Needham et al. investigated the transcriptional effects of low SES [<xref ref-type="bibr" rid="B100-ijms-21-05094">100</xref>]. They reported that low (current) adult SES altered the expression of several genes intimately linked to inflammation that are all linked to T2D: <italic>F8</italic> [<xref ref-type="bibr" rid="B101-ijms-21-05094">101</xref>], <italic>CD1D</italic> [<xref ref-type="bibr" rid="B102-ijms-21-05094">102</xref>], <italic>KLRG1</italic> [<xref ref-type="bibr" rid="B103-ijms-21-05094">103</xref>], <italic>NLRP12</italic> [<xref ref-type="bibr" rid="B104-ijms-21-05094">104</xref>], and <italic>TLR3</italic> [<xref ref-type="bibr" rid="B105-ijms-21-05094">105</xref>] and stress related gene <italic>AVP</italic> [<xref ref-type="bibr" rid="B106-ijms-21-05094">106</xref>]. Furthermore, low early-life SES was also shown to affect the expression of stress related genes: <italic>FKBP5</italic> [<xref ref-type="bibr" rid="B107-ijms-21-05094">107</xref>] <italic>OXTR</italic> [<xref ref-type="bibr" rid="B108-ijms-21-05094">108</xref>] and <italic>AVP</italic> and inflammation associated genes: <italic>CD1D</italic> and <italic>CCL1.</italic> As such, SES would appear to act on inflammatory pathways that are common to low SES environments and eventually T2D, and may worsen the T2D etiopathology by targeting prominent pathophysiological factors like stress and inflammation. The mechanistic link between ELA and T2D is re-enforced by the immune disturbances reported. Patients with T2D have a larger number senescent CD8+ cytotoxic T cells and higher levels of systemic inflammation [<xref ref-type="bibr" rid="B109-ijms-21-05094">109</xref>,<xref ref-type="bibr" rid="B110-ijms-21-05094">110</xref>] that may explain the higher incidence of viral and bacterial infections in diabetic patients [<xref ref-type="bibr" rid="B111-ijms-21-05094">111</xref>].</p>
<p>Although there is no data currently available, it is logical to assume that although T2D may predict COVID-19 severity, the origins of this link may lie in the lifelong pro-inflammatory environment induced by ELA. T2D may be the adult manifestation of the poor early life social environment which then mediates the effect between ELA and COVID-19.</p>
</sec>
<sec id="sec5-ijms-21-05094">
<title>5. The COVID-19 Immune Response, SES and Early Life Adversity</title>
<p><italic>The immune response to COVID-19:</italic> The SARS-CoV-2, like other viruses, is considered immunologically as an intracellular parasite. In general, the viral infectious-cycle starts with a short-lived extracellular period, followed by cell entry, with a final, longer, intracellular replicative period. In the classical anti-viral immune response, the immune system attacks all phases of the viral cycle using both antigen specific and non-specific mechanisms. The non-specific immune response, particularly effective in the early phase of infection, is mainly mediated through natural killer cells and interferons. Production and/or secretion of type-1 interferons (i.e., all the interferons proteins except IFN-Î³) enhances NK cell ability to lyse infected cells as well as inhibits viral reproduction and cellular proliferation. When an adaptive immune response has been mounted, the most effective antibodies are the so-called neutralizing antibodies which block viral entry into the host cell by binding to viral surface proteins such as the envelope or capsid protein (<xref ref-type="fig" rid="ijms-21-05094-f002">Figure 2</xref>). When the subsequent cell-mediated immunity enters into force, it is principally CD8+ cytotoxic T lymphocytes (CTLs) that are the effector cells. CTLs recognize MHC class-I presented antigens, to lyse the presenting cell, a response that is not always beneficial as the damage done by the cytotoxic cells is occasionally greater than that of the virus itself.</p>
<p>As the COVID-19 pandemic has progressed, there have been several reports of the anti-SARS-Cov-2 immune response. To date, the data suggests that the response is a classical anti-viral response with activation of Type-1 interferons and CD8+ CTLs. Although Thevarajan et al., analyzed a single patient, they nicely demonstrated the kinetics of the anti-SARS-CoV-2 immune response [<xref ref-type="bibr" rid="B112-ijms-21-05094">112</xref>]. In a manner similar to both Influenza infection and a previous SARS-CoV-2 report [<xref ref-type="bibr" rid="B113-ijms-21-05094">113</xref>] which showed that the numbers of CD38<sup>+</sup>HLA-DR<sup>+</sup> CD8<sup>+</sup> T cells were higher in infected patients than in healthy controls, and rapidly increased from 3.57% (day 7), 5.32% (day 8) to a peak at 11.8% 9-days later. By day 20 they had decreased slightly to 7.05%. As would be expected, CD38<sup>+</sup>HLA-DR<sup>+</sup>CD8<sup>+</sup> CTLs, produced significant quantities of the lytic moietiesâperforin, granzyme A and granzyme Bânecessary to lyse virus-infected cells (<xref ref-type="fig" rid="ijms-21-05094-f002">Figure 2</xref>). Their kinetic data showed that this occurred at days 7â9, preceding symptom resolution, suggesting an important role in the resolution of the SARS-CoV-2 immune response [<xref ref-type="bibr" rid="B112-ijms-21-05094">112</xref>].</p>
<p><italic>The anti SARS-CoV-2 immune response in severe/critical patients:</italic> COVID-19 patients are generally considered either mild, severe, or critical. There are now data on the differences in the immune response in these different categories, although the categories are not always the same, complicating comparisons between studies. When Zheng et al. investigated T-cell derived functional molecules, they highlighted lower levels of interferon-Î³ (IFN-Î³) and TNF-Î± in CD4+ T cells in severely affected patients than those mildly affected, although in the latter, they were considerably higher than expected in health controls [<xref ref-type="bibr" rid="B114-ijms-21-05094">114</xref>]. Levels of perforin and granzyme B cells were increased in CD8+TIGIT- CTLs, and the numbers of senescent HLA-DR+ TIGIT+ CD8+ cells were increased in severely affected patients than those with a mild infection. The authors proposed that their data suggests COVID-19, like many chronic viral infections, reduces CD4-Tcell functionality, skewing the immune response towards a CD8+ response, with excessive activation leading to exhaustion of the CD8+ cells, diminishing the anti-viral immune reaction. Furthermore, upon deeper examination, they found differences in PD-1, CTLA-4, and TIGITâmarkers of immune exhaustion. In severely affected patients, exhausted PD1+CTLA-4+TIGIT+ cells were significantly more frequent than in patients with a milder infection. This excessive CTL exhaustion may reduce the effectiveness of the immune response to SARS-CoV-2, explaining case severity [<xref ref-type="bibr" rid="B114-ijms-21-05094">114</xref>]. Furthermore, in an independent study, it was also reported that as disease severity increases, the numbers of naÃ¯ve, effector and memory classes of CD8+ T cells diminish, while B-cell, and CD4+ T cell numbers generally increase [<xref ref-type="bibr" rid="B115-ijms-21-05094">115</xref>,<xref ref-type="bibr" rid="B116-ijms-21-05094">116</xref>]. Overall, we interpret these data as showing that a functional CD8 response is required to clear SARS-CoV-2 infection, and COVID-19 severity is increased as the CD8+ response becomes somehow diminished (<xref ref-type="fig" rid="ijms-21-05094-f002">Figure 2</xref>). Indeed, Omarjee et al. have also come to a similar conclusion, that âSevere COVID-19 can therefore mimic a state of immune senescenceâ [<xref ref-type="bibr" rid="B117-ijms-21-05094">117</xref>,<xref ref-type="bibr" rid="B118-ijms-21-05094">118</xref>]. From the start of the pandemic, the involvement of the cytokine system was clear [<xref ref-type="bibr" rid="B119-ijms-21-05094">119</xref>]. Initially described in January 2020, levels of CXCL8 and IFNÎ³, were increased in all COVID-19 patients, and severe cases had significantly higher levels CXCL10, CCL2 and TNFÎ± than milder cases [<xref ref-type="bibr" rid="B120-ijms-21-05094">120</xref>] reproduced in a more recent study that also observed increased levels of IL6, and IL 10 in the most severe cases [<xref ref-type="bibr" rid="B121-ijms-21-05094">121</xref>].</p>
<p><italic>Does Immunosenescence link ELA to COVID-19 outcomes?</italic> We have outlined above the ELA-induced long term immunophenotype. Although the origins are multifactorial, it would appear, from the work of Elwenspoek [<xref ref-type="bibr" rid="B27-ijms-21-05094">27</xref>,<xref ref-type="bibr" rid="B28-ijms-21-05094">28</xref>] and Reid [<xref ref-type="bibr" rid="B29-ijms-21-05094">29</xref>], that an adverse social environment in early life drive T-cells, in particular CD8+ CTLs, towards a senescent state. When the different aspects of ELA are considered separately, immunosenescence would appear to be a common aspect. Senescence and exhaustion may have similar outcomes, a reduced immune reaction, but are distinct processes [<xref ref-type="bibr" rid="B122-ijms-21-05094">122</xref>]. Senescent cells have a significantly reduced capacity to proliferate, however, they have a strong pro-inflammatory action. In a manner reminiscent of the senescence associated secretory phenotype (SASP) initially established in fibroblasts [<xref ref-type="bibr" rid="B123-ijms-21-05094">123</xref>] senescent CD8+ CTLs aggregate in the highly differentiated states (effector memory and TEMRA), are highly resistant to apoptosis, and produce significant quantities of pro-inflammatory cytokines such as IL6 and TNFÎ± upon stimulation [<xref ref-type="bibr" rid="B124-ijms-21-05094">124</xref>]. Exhausted CD8+ CTLs however, are not only unable to proliferate, but they no longer secrete cytokines after stimulation and are programed to undergo apoptosis.</p>
<p>The data currently available suggests that the aggregation of senescent CTLs will negatively impact the progression of COVID-19, and patients with the most senescent CTLs will have the poorest prognosis as they are less capable of mounting an effective CD8+ response, and they will have an exaggerated cytokine secretion from the senescent cells. This is further supported by the recent initiation of the SCOPE trial, âSirolimus Treatment in Hospitalized Patients With COVID-19 Pneumoniaâ (NCT04341675). In this trial, the investigators propose administering rapamycin to down-regulate the IL-6 pathway through the mTOR pathway to not only reduce IL-Î² levels, but reduce the number of senescent T-cells as well [<xref ref-type="bibr" rid="B117-ijms-21-05094">117</xref>]. This also raises the question about what happens to COVID-19 when ELA-induced senescence and COVID-induced exhaustion converge. It would seem logical to hypothesize that this would represent the worst-case scenario, and would produce the least-effective cytotoxic T cell response.</p>
<p><italic>The Conserved Transcriptional Response to Adversity (CTRA):</italic> Studies have demonstrated that early life social adversity can act mechanistically through modifications of gene expression patterns. Gene expression implicated in the activation of T-lymphocyte and inflammation was enhanced while gene expression implicated in innate antiviral responses induced by type I IFN and innate antimicrobial responses of pathogen-specific was reduced [<xref ref-type="bibr" rid="B125-ijms-21-05094">125</xref>]. These patterns of altered gene expression remain lifelong [<xref ref-type="bibr" rid="B125-ijms-21-05094">125</xref>]. The pattern has been termed the conserved transcriptional response to adversity (CTRA), and has been noticed in many correlational studies regarding humans encountering with adverse life circumstances. [<xref ref-type="bibr" rid="B126-ijms-21-05094">126</xref>,<xref ref-type="bibr" rid="B127-ijms-21-05094">127</xref>,<xref ref-type="bibr" rid="B128-ijms-21-05094">128</xref>,<xref ref-type="bibr" rid="B129-ijms-21-05094">129</xref>,<xref ref-type="bibr" rid="B130-ijms-21-05094">130</xref>,<xref ref-type="bibr" rid="B131-ijms-21-05094">131</xref>,<xref ref-type="bibr" rid="B132-ijms-21-05094">132</xref>,<xref ref-type="bibr" rid="B133-ijms-21-05094">133</xref>]. CTRA dynamics are most strongly induced by social conditions in early life, at the first step of the development of postnatal immune system [<xref ref-type="bibr" rid="B125-ijms-21-05094">125</xref>]. To the extent that transcriptome remodeling induced environmentally continue to affect immune responses of implicated pathogen, many, many years later in life (e.g., inhibiting immune responses to viral infections [<xref ref-type="bibr" rid="B134-ijms-21-05094">134</xref>], or amplifying allergic inflammation [<xref ref-type="bibr" rid="B133-ijms-21-05094">133</xref>,<xref ref-type="bibr" rid="B135-ijms-21-05094">135</xref>]).</p>
<p><italic>Essential co-variates:</italic> ELA is, however, associated with a range of negative health behaviors (reviewed in [<xref ref-type="bibr" rid="B136-ijms-21-05094">136</xref>]) including an increased risk of smoking as well as increased smoking levels, levels of alcohol consumption, and poor diet leading to either malnourishment or obesity. The psychobiological and neurodevelopmental mechanisms linking ELA and risky health behaviors are starting to be dissected [<xref ref-type="bibr" rid="B137-ijms-21-05094">137</xref>]. However, in the context of the COVID-19 pandemic, it would appear from the numerous studies that are becoming available that smoking increases the risk not only of hospitalization with COVID-19, but with ICU admission and death (odds ratio from 2.0 to 16 [<xref ref-type="bibr" rid="B138-ijms-21-05094">138</xref>,<xref ref-type="bibr" rid="B139-ijms-21-05094">139</xref>]) and was confirmed in recent meta analyses of the available studies [<xref ref-type="bibr" rid="B140-ijms-21-05094">140</xref>,<xref ref-type="bibr" rid="B141-ijms-21-05094">141</xref>,<xref ref-type="bibr" rid="B142-ijms-21-05094">142</xref>,<xref ref-type="bibr" rid="B143-ijms-21-05094">143</xref>]. On the other hand, there is little evidence available on the role of prior alcohol intake on the course of SARS-CoV-2 infection, however, considerable public health efforts are being made to combat alcohol abuse during the confinement period, and a prior history of ELA exposure may increase the risk of excessive alcohol consumption during this period.</p>
<p>Biological sex is one of the strongest drivers of the heterogeneity in COVID-19 disease severity. There is a clearly more favorable outcome for women across all age categories. The data available so far suggests that sexual dimorphism in the immune system may play a role in determining disease outcome. Sex impacts not only the development of T<sub>reg</sub> cells, but the distribution of lymphocyte subsets and the overall T-lymphocyte response to challenge [<xref ref-type="bibr" rid="B144-ijms-21-05094">144</xref>]. Many immunologically important genes are found on the X-chromosome including CD40L and CXCR3. Incomplete X-inactivation or epigenetic modifications will induce sex-specific effects on T-cells [<xref ref-type="bibr" rid="B145-ijms-21-05094">145</xref>,<xref ref-type="bibr" rid="B146-ijms-21-05094">146</xref>]. There is also evidence that there is a stronger lymphopenia in males than females in severe COVID-19 disease [<xref ref-type="bibr" rid="B147-ijms-21-05094">147</xref>,<xref ref-type="bibr" rid="B148-ijms-21-05094">148</xref>]</p>
<p>There is also growing evidence for the role of vitamins D and K in the outcome of COVID -19 disease. Beyond its classical role in bone metabolism [<xref ref-type="bibr" rid="B149-ijms-21-05094">149</xref>], vitamin D plays a role in the functioning of the immune system and in the regulation of inflammatory cytokines [<xref ref-type="bibr" rid="B150-ijms-21-05094">150</xref>] and CRP [<xref ref-type="bibr" rid="B149-ijms-21-05094">149</xref>] which reduces the risk of infection and cardiovascular disease [<xref ref-type="bibr" rid="B149-ijms-21-05094">149</xref>]. Indeed, immune cells like T-cells, B-cells or antigen presenting cells can directly interact with vitamin D receptors. In this way, increased vitamin D levels enhance the innate system and suppress the adaptive immune system, which demonstrates its role in immune regulation [<xref ref-type="bibr" rid="B151-ijms-21-05094">151</xref>]. Vitamin D deficiency is also linked to comorbidities such as diabetes [<xref ref-type="bibr" rid="B152-ijms-21-05094">152</xref>] and upper respiratory disease susceptibility, including common viral infections, allergies and airway inflammatory conditions (REF6). The logical assumption is that a possible explanation on the susceptibility of the elderly population is the fact that they naturally produce less vitamin D while they are exposed to less sunlight as many stay indoors. Considering also that the pandemic first made its global appearance during winter season increases the possibility for this correlative association [<xref ref-type="bibr" rid="B152-ijms-21-05094">152</xref>]. Panfili et al. highlighted the potential that vitamin D supplementation has shown to be a successful cost-effective therapeutic for acute respiratory tract infections (ARTIs) in low socio-economic characterized countries [<xref ref-type="bibr" rid="B153-ijms-21-05094">153</xref>]. In addition, studies have shown that vitamin D can help to reduce the risk of an activated renin-angiotensin system in the lung [<xref ref-type="bibr" rid="B154-ijms-21-05094">154</xref>] in cases of severe COVID-19 disease in patients with hypertension and high expression of ACE2 receptors [<xref ref-type="bibr" rid="B155-ijms-21-05094">155</xref>]. On the other hand, patients with comorbidities such as diabetes present a lack in vitamin K which is involved in blood coagulation or bone calcification mechanisms. In case of COVID-19 patients, insufficient levels of vitamin K could be associated with a risk of complications due to elastic fiber pathologies such as idiopathic pulmonary fibrosis (IPF) [<xref ref-type="bibr" rid="B156-ijms-21-05094">156</xref>]. Coagulation has been reported as a common comorbidity linked to COVID-19 severity and mortality.</p>
</sec>
<sec id="sec6-ijms-21-05094">
<title>6. COVID-19 as a Natural Experiment</title>
<p>Given the obvious ethical objections to experimental studies manipulating the early life environment, there is a long history of using natural experiments. There are two classical natural experiments looking at the early life social environment, Project Ice Storm in Canada, and the Dutch Hunger Winter. When we look at these natural experiments in the light of the three-hit model, these examined the role of the second hit, the early life environment.</p>
<p>Project Ice storm is based on the 1998 Quebec ice storm and examines the impact of prenatal stress on adult outcomes. This particularly harsh meteorological event affected, residents of a well delineated area covering Nova Scotia, New Brunswick, Southern Quebec and eastern Ontario. These populations had to deal with a situation where they were deprived of electricity for weeks, and in certain cases months, as well as the shutdown of all activities in major cities (Montreal, Ottawa) as well as military deployment and several deaths. Project Ice Storm went on to examine the effects over the following 20 years on the children and now young adults that were exposed to the storm in utero [<xref ref-type="bibr" rid="B157-ijms-21-05094">157</xref>,<xref ref-type="bibr" rid="B158-ijms-21-05094">158</xref>]. They concluded that prenatal glucocorticoid exposure impacted a variety of outcomes in the next generation throughout childhood and persisting into adulthood, dysregulating metabolic pathways and the HPA axis [<xref ref-type="bibr" rid="B157-ijms-21-05094">157</xref>,<xref ref-type="bibr" rid="B159-ijms-21-05094">159</xref>] This was mediated through epigenetic (DNA methylation) encoding of the stormâs effect [<xref ref-type="bibr" rid="B158-ijms-21-05094">158</xref>]. Project Ice Storm demonstrated that an environmental stressor can have long-term effects and inducing numerous outcomes although there were additional mechanisms linked to socioeconomic factors that are still to be identified.</p>
<p>The Dutch Hunger Winter was the consequence of a food embargo placed on the Dutch population by the Germans at the end of world war II [<xref ref-type="bibr" rid="B160-ijms-21-05094">160</xref>]. Here, the importance of timing of the adversity in the programing of adult disease was established [<xref ref-type="bibr" rid="B161-ijms-21-05094">161</xref>]. Working on same-sex sibling pairs of which only one was exposed to famine they demonstrated that in utero exposure induced an adverse metabolic [<xref ref-type="bibr" rid="B162-ijms-21-05094">162</xref>] or mental phenotype [<xref ref-type="bibr" rid="B163-ijms-21-05094">163</xref>], depending on the time of exposure and fetal sex, and that this was mediated by DNA methylation [<xref ref-type="bibr" rid="B164-ijms-21-05094">164</xref>].</p>
<p>As Project Ice Storm disaster and the Dutch hunger winter, the current COVID-19 pandemic must be considered as a relevant natural experiment to reveal the effects of socioeconomic factors on health and disease. In the context of the three-hit model, here we have an exquisite and unique opportunity to investigate the third hit. As outlined above, the early life period acts through underlying mechanisms such as DNA methylation and programing of the immune system to influence disease progression and severity later in life. These prior studies have provided unexpected mechanistic insight into the immunological consequences of early life stress exposure. Drawing parallels with COVID, if we can collect the correct data, we can start to unpick the role of the whole life trajectory and how this contributes to disease risk through a pro-inflammatory immune bias.</p>
<p>COVID-19 may also be a form of early life adversity. It is yet to be discovered whether SARS-Cov-2 could have any immune programing capacity after an early life infection and what consequences could appear years later. Its strong association and impact on the early life microbiome is unknown. Pregnant women who tested positive for SARS-CoV-2 infection showed evidence of placental injury which impeded blood flow to the fetus [<xref ref-type="bibr" rid="B165-ijms-21-05094">165</xref>]. Placental development is the first step in embryogenesis and may determine the quality of the intra-uterine environment [<xref ref-type="bibr" rid="B165-ijms-21-05094">165</xref>,<xref ref-type="bibr" rid="B166-ijms-21-05094">166</xref>]. Individuals who were exposed (intra-uterine) to the Spanish flu of 1918 have been reported to face lifelong low SES and cardiovascular diseases [<xref ref-type="bibr" rid="B167-ijms-21-05094">167</xref>] which may be indicative of a bidirectional risk that has crossed over from the placenta jeopardizing their lifelong health profile. It is quite possible that the COVID-19 positive mothers pass on a similar risk to subsequent generations, serving as an ELA event, which ultimately makes them highly susceptible. Thus, these cases need strict follow up studies to validate this hypothesis.</p>
</sec>
<sec id="sec7-ijms-21-05094">
<title>7. Data that Should Be Collected</title>
<p>In light of the data presented here, it is clear that there are many types of data that should be collected in addition to the studies that are currently ongoing addressing the epidemiology and biology of COVID-19. As recently highlighted, it is essential to collect as much socioeconomic data as possible during the ongoing pandemic [<xref ref-type="bibr" rid="B16-ijms-21-05094">16</xref>]. Data collection should be expanded to include retrospective data on life-trajectories and both exposure to adverse life events and how importantly they were perceived. There are well-recognized difficulties in retrospectively assessing adversity or the overall life-course, however, there are tools available that can measure the prior traumatic experiences. Recent adult trauma can be addressed by a brief questionnaire that covers the perceived importance (salience) of a range of stressful life events including âseparation, relationship and money worries, accidents, illness and death, job loss, and violenceâ [<xref ref-type="bibr" rid="B168-ijms-21-05094">168</xref>] that any future study participants may have experienced. To address traumatic experiences earlier in life, there are also validated questionnaires such as the Childhood Trauma Questionnaire CTQ or the Early Trauma Index that are available [<xref ref-type="bibr" rid="B169-ijms-21-05094">169</xref>]. However, as with any retrospective study there is a risk of recall bias, although the validated questionnaires have questions within them to ensure internal consistency. Furthermore, in the context of a fast-moving pandemic, the ability to transpose such questionnaires to an online system is known to improve the accuracy of responses as the anonymity of the online process has been shown to reduce both social desirability and central coherence biases, although there is a potential risk of questions being mis-interpreted by participants [<xref ref-type="bibr" rid="B170-ijms-21-05094">170</xref>]. All such tools are limited by what was thought of as being traumatic when they were developed, however, they remain the standard tool for assessing traumatic events during childhood as well as a poor social and familial environment [<xref ref-type="bibr" rid="B169-ijms-21-05094">169</xref>]. The use of such questionnaires has already proven useful. Adverse social conditions, as measured by the CTQ have been shown to become embedded as functional changes in the immune system that are visible lifelong. Studies have shown adversity measured by the CTQ over a period of as little as 4 months changes the immune response up to 24 years later, the longest time-point investigated so far [<xref ref-type="bibr" rid="B27-ijms-21-05094">27</xref>,<xref ref-type="bibr" rid="B28-ijms-21-05094">28</xref>,<xref ref-type="bibr" rid="B34-ijms-21-05094">34</xref>,<xref ref-type="bibr" rid="B125-ijms-21-05094">125</xref>]. Tools such as the CTQ should play a role in studies addressing the overall disease severity if participants go on to develop COVID-19 rather than whether ELA plays a role in the overall prevalence of infection. Furthermore, health related behaviors such as smoking and alcohol consumption which are known to be elevated after ELA and may also play a role in the clinical evolution or susceptibility to SARS-CoV-2 infection must be recorded. All data should be analyzed with a sex-informed approach, taking differences in the immune system into account.</p>
<p>The collection of life-event meta-data must be complemented by the collection of the correct biological samples. We have highlighted the role of the immune system, the microbiome and pollution levels. It would seem logical to obtain stool and blood samples, and the markers to be investigated such as TIGIT, PD-1, CD28 and CD57 are now becoming clear. Furthermore, such biosampling would allow the analysis of vitamin levels, as they may be a key link in the pathophysiological chain. It would also appear to be appropriate to rapidly collect measures of pollutants, determine how indoor and outdoor pollution levels have changes, how, with the strict confinement measures imposed, nutrition has changes. All of these will play into the susceptibility and immune response.</p>
<p>The data reviewed here highlights the role that the social environment will play in determining morbidity and mortality during the COVID-19 pandemic. In the future, such socioeconomic and lifestyle data must be considered as essential clinical data that is then analyzed concurrently with biological material to tease out the effects of the environment in health and disease.</p>
</sec>
<sec id="sec8-ijms-21-05094" sec-type="conclusions">
<title>8. Conclusions</title>
<p>The developmental origins of health and disease is firmly established for many non-communicable diseases. The current COVID-19 pandemic has shown that there are many health disparities, and the available (preliminary) data suggests that there is a strong socioeconomic impact on morbidity, and potentially mortality. Although there are no data so-far available to link the early life period to the morbidity and mortality of an infectious disease, an adverse early life environment would appear to impact the immune system and make it less efficient in fighting subsequent viral infections. Early-life researchers have a long history of taking advantage of natural experiments, teasing out the long-term consequences of ELA to produce a measurable phenotype many years, or even generations, later. The current pandemic can turn this paradigm on its head. Many discrepancies and inequalities in COVID-19 morbidity and mortality have been reported, and if the correct data is collected it may be possible to separate the early life elements that have made people particularly vulnerable to COVID-19 many years later. This will, naturally, then help us identify those that are most at risk from developing the severest forms of COVID-19. In order to do this, we need to recognize socioeconomic and early-life factors as genuine medically and clinically relevant data that urgently need to be collected. Finally, many biological samples have been collected in the ongoing studies. The mechanisms linking the early life environment with a defined later-life phenotype are starting to be elucidated, and perhaps hold the key to understanding inequalities and differences in the severity of COVID-19.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The authors would like to thank Sophie MÃ©riaux, Stephanie Schmitz, Pauline Guebels, Fanny Bonnemberger for their technical support over the last years that has enabled our research into the effects of early life adversity.</p>
</ack>
<notes>
<title>Author Contributions</title>
<p>Conceptualization. J.D.T. and C.H.; Literature review, C.H., S.B.F., S.V.S., M.P.M., E.G.C., N.G., J.D.T.; Writingâoriginal draft, C.H., S.B.F., S.V.S., M.P.M., E.G.C., N.G., J.D.T.; writingâreview and editing, C.H., S.B.F., S.V.S., M.P.M., E.G.C., N.G., J.D.T. All authors have read and agreed to the published version of the manuscript.</p>
</notes>
<notes>
<title>Funding</title>
<p>The work of JDT on the long term effects of ELA was funded by the Fonds National de Recherche (FNR) Luxembourg (C12/BM/3985792 âEpiPathâ). JDT together with CH, SBF, SVS, MPM and EGC are funded by the FNR (CON-VINCE &amp; C19/SC/13650569, âALACâ; C16/BM/11342695 âMetCOEPsâ; INTER/ANR/16/11568350 âMADAMâ; PRIDE/11012546/NEXTIMMUNE and PRIDE17/11823097/MicrOH respectively. JDT is a management board member of the EU-funded COST actions CA18211 and CA16120.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-ijms-21-05094">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shah</surname>
<given-names>S.G.S.</given-names>
</name>
<name>
<surname>Farrow</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>A commentary on âWorld Health Organization declares global emergency: A review of the 2019 novel Coronavirus (COVID-19)</article-title>
<source/>â Int. J. Surg.
          <year>2020</year>
<volume>76</volume>
<fpage>128</fpage>
<lpage>129</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijsu.2020.03.001</pub-id>
<pub-id pub-id-type="pmid">32169574</pub-id>
</element-citation>
</ref>
<ref id="B2-ijms-21-05094">
<label>2.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Snoeck</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Vaillant</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Abdelrahman</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Satagopam</surname>
<given-names>V.P.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Beaumont</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>C.P.C.</given-names>
</name>
<name>
<surname>Fritz</surname>
<given-names>J.V.</given-names>
</name>
<name>
<surname>SchrÃ¶der</surname>
<given-names>V.E.</given-names>
</name>
<name>
<surname>Kaysen</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<source/>Prevalence of SARS-CoV-2 Infection in the Luxembourgish Population: The CON-VINCE Study
          <publisher-name>Cold Spring Harbor Laboratory</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>2020</year>
</element-citation>
</ref>
<ref id="B3-ijms-21-05094">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seeman</surname>
<given-names>T.E.</given-names>
</name>
</person-group>
<article-title>Social ties and health: The benefits of social integration</article-title>
<source/>Ann. Epidemiol.
          <year>1996</year>
<volume>6</volume>
<fpage>442</fpage>
<lpage>451</lpage>
<pub-id pub-id-type="doi">10.1016/S1047-2797(96)00095-6</pub-id>
<pub-id pub-id-type="pmid">8915476</pub-id>
</element-citation>
</ref>
<ref id="B4-ijms-21-05094">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cassel</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>The contribution of the social environment to host resistance: The Fourth Wade Hampton Frost Lecture</article-title>
<source/>Am. J. Epidemiol.
          <year>1976</year>
<volume>104</volume>
<fpage>107</fpage>
<lpage>123</lpage>
<pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a112281</pub-id>
<pub-id pub-id-type="pmid">782233</pub-id>
</element-citation>
</ref>
<ref id="B5-ijms-21-05094">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avitsur</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hunzeker</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sheridan</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Role of early stress in the individual differences in host response to viral infection</article-title>
<source/>Brain Behav. Immun.
          <year>2006</year>
<volume>20</volume>
<fpage>339</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2005.09.006</pub-id>
<pub-id pub-id-type="pmid">16289758</pub-id>
</element-citation>
</ref>
<ref id="B6-ijms-21-05094">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakamura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Sominsky</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rosengren</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Hodgson</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>Maternal separation in early life impairs tumor immunity in adulthood in the F344 rat</article-title>
<source/>Stress
          <year>2011</year>
<volume>14</volume>
<fpage>335</fpage>
<lpage>343</lpage>
<pub-id pub-id-type="doi">10.3109/10253890.2010.548014</pub-id>
<pub-id pub-id-type="pmid">21438770</pub-id>
</element-citation>
</ref>
<ref id="B7-ijms-21-05094">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hales</surname>
<given-names>C.N.</given-names>
</name>
<name>
<surname>Barker</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Fall</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Osmond</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>P.D.</given-names>
</name>
</person-group>
<article-title>Fetal and infant growth and impaired glucose tolerance at age 64</article-title>
<source/>BMJ
          <year>1991</year>
<volume>303</volume>
<fpage>1019</fpage>
<lpage>1022</lpage>
<pub-id pub-id-type="doi">10.1136/bmj.303.6809.1019</pub-id>
<pub-id pub-id-type="pmid">1954451</pub-id>
</element-citation>
</ref>
<ref id="B8-ijms-21-05094">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rose</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pennington</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McHale</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Buchan</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Taylor-Robinson</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Barr</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Inequalities in COVID19 mortality related to ethnicity and socioeconomic deprivation</article-title>
<source/>medRxiv
          <year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.04.25.20079491</pub-id>
</element-citation>
</ref>
<ref id="B9-ijms-21-05094">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hertzman</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Boyce</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>How Experience Gets Under the Skin to Create Gradients in Developmental Health</article-title>
<source/>Annu. Rev. Public Health
          <year>2010</year>
<volume>31</volume>
<fpage>329</fpage>
<lpage>347</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.publhealth.012809.103538</pub-id>
<pub-id pub-id-type="pmid">20070189</pub-id>
</element-citation>
</ref>
<ref id="B10-ijms-21-05094">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phelan</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Link</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Tehranifar</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Social Conditions as Fundamental Causes of Health Inequalities: Theory, Evidence, and Policy Implications</article-title>
<source/>J. Health Soc. Behav.
          <year>2010</year>
<volume>51</volume>
<fpage>28</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1177/0022146510383498</pub-id>
</element-citation>
</ref>
<ref id="B11-ijms-21-05094">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wadhwa</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Buss</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Entringer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Developmental Origins of Health and Disease: Brief History of the Approach and Current Focus on Epigenetic Mechanisms</article-title>
<source/>Semin. Reprod. Med.
          <year>2009</year>
<volume>27</volume>
<fpage>358</fpage>
<lpage>368</lpage>
<pub-id pub-id-type="doi">10.1055/s-0029-1237424</pub-id>
<pub-id pub-id-type="pmid">19711246</pub-id>
</element-citation>
</ref>
<ref id="B12-ijms-21-05094">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gluckman</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Beedle</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Non-genomic transgenerational inheritance of disease risk</article-title>
<source/>BioEssays
          <year>2007</year>
<volume>29</volume>
<fpage>145</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="doi">10.1002/bies.20522</pub-id>
<pub-id pub-id-type="pmid">17226802</pub-id>
</element-citation>
</ref>
<ref id="B13-ijms-21-05094">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gluckman</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Developmental origins of health and disease: Reducing the burden of chronic disease in the next generation</article-title>
<source/>Genome Med.
          <year>2010</year>
<volume>2</volume>
<fpage>14</fpage>
<pub-id pub-id-type="doi">10.1186/gm135</pub-id>
<pub-id pub-id-type="pmid">20236494</pub-id>
</element-citation>
</ref>
<ref id="B14-ijms-21-05094">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daskalakis</surname>
<given-names>N.P.</given-names>
</name>
<name>
<surname>Bagot</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Vinkers</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>De Kloet</surname>
<given-names>E.R.</given-names>
</name>
</person-group>
<article-title>The three-hit concept of vulnerability and resilience: Toward understanding adaptation to early-life adversity outcome</article-title>
<source/>Psychoneuroendocrinology
          <year>2013</year>
<volume>38</volume>
<fpage>1858</fpage>
<lpage>1873</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2013.06.008</pub-id>
<pub-id pub-id-type="pmid">23838101</pub-id>
</element-citation>
</ref>
<ref id="B15-ijms-21-05094">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grova</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Schroeder</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Olivier</surname>
<given-names>J.-L.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Epigenetic and Neurological Impairments Associated with Early Life Exposure to Persistent Organic Pollutants</article-title>
<source/>Int. J. Genom.
          <year>2019</year>
<volume>2019</volume>
<fpage>1</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1155/2019/2085496</pub-id>
</element-citation>
</ref>
<ref id="B16-ijms-21-05094">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khalatbari-Soltani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cumming</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Delpierre</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kelly-Irving</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Importance of collecting data on socioeconomic determinants from the early stage of the COVID-19 outbreak onwards</article-title>
<source/>J. Epidemiol. Commun. Health
          <year>2020</year>
<pub-id pub-id-type="doi">10.1136/jech-2020-214297</pub-id>
</element-citation>
</ref>
<ref id="B17-ijms-21-05094">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Britten</surname>
<given-names>R.H.</given-names>
</name>
</person-group>
<article-title>The Incidence of Epidemic Influenza, 1918â1919: A Further Analysis According to Age, Sex, and Color of the Records of Morbidity and Mortality Obtained in Surveys of 12 Localities</article-title>
<source/>Public Health Rep. (1896â1970)
          <year>1932</year>
<volume>47</volume>
<fpage>303</fpage>
<pub-id pub-id-type="doi">10.2307/4580340</pub-id>
</element-citation>
</ref>
<ref id="B18-ijms-21-05094">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sydenstricker</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>The Incidence of Influenza among Persons of Different Economic Status during the Epidemic of 1918</article-title>
<source/>Public Health Rep. (1896â1970)
          <year>1931</year>
<volume>46</volume>
<fpage>154</fpage>
<pub-id pub-id-type="doi">10.2307/4579923</pub-id>
</element-citation>
</ref>
<ref id="B19-ijms-21-05094">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>La Ruche</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tarantola</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Barboza</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vaillant</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gueguen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gastellu-Etchegorry</surname>
<given-names>M.</given-names>
</name>
<collab>Epidemic Intelligence Team at InVS</collab>
</person-group>
<article-title>The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the Pacific</article-title>
<source/>Eurosurveillance
          <year>2009</year>
<volume>14</volume>
<pub-id pub-id-type="doi">10.2807/ese.14.42.19366-en</pub-id>
</element-citation>
</ref>
<ref id="B20-ijms-21-05094">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yancy</surname>
<given-names>C.W.</given-names>
</name>
</person-group>
<article-title>COVID-19 and African Americans</article-title>
<source/>JAMA
          <year>2020</year>
<volume>323</volume>
<fpage>1891</fpage>
<pub-id pub-id-type="doi">10.1001/jama.2020.6548</pub-id>
</element-citation>
</ref>
<ref id="B21-ijms-21-05094">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whittle</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Diaz-Artiles</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>An ecological study of socioeconomic predictors in detection of COVID-19 cases across neighborhoods in New York City</article-title>
<source/>medRxiv
          <year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.04.17.20069823</pub-id>
</element-citation>
</ref>
<ref id="B22-ijms-21-05094">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guha</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bonsu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dey</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Addison</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Community and Socioeconomic Factors Associated with COVID-19 in the United States: Zip code level cross sectional analysis</article-title>
<source/>medRxiv
          <year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.04.19.20071944</pub-id>
</element-citation>
</ref>
<ref id="B23-ijms-21-05094">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan</article-title>
<source/>Crit. Care
          <year>2020</year>
<volume>24</volume>
<fpage>1</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1186/s13054-020-2833-7</pub-id>
<pub-id pub-id-type="pmid">31898531</pub-id>
</element-citation>
</ref>
<ref id="B24-ijms-21-05094">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pareek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bangash</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Pareek</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sze</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Minhas</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Hanif</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Khunti</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Ethnicity and COVID-19: An urgent public health research priority</article-title>
<source/>Lancet
          <year>2020</year>
<volume>395</volume>
<fpage>1421</fpage>
<lpage>1422</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30922-3</pub-id>
<pub-id pub-id-type="pmid">32330427</pub-id>
</element-citation>
</ref>
<ref id="B25-ijms-21-05094">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hengesch</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Elwenspoek</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Schaan</surname>
<given-names>V.K.</given-names>
</name>
<name>
<surname>Larra</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Finke</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Bachmann</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>VÃ¶gele</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>C.P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Blunted endocrine response to a combined physical-cognitive stressor in adults with early life adversity</article-title>
<source/>Child Abus. Negl.
          <year>2018</year>
<volume>85</volume>
<fpage>137</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1016/j.chiabu.2018.04.002</pub-id>
</element-citation>
</ref>
<ref id="B26-ijms-21-05094">
<label>26.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>DeWitt</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Luebke</surname>
<given-names>R.W.</given-names>
</name>
</person-group>
<article-title>Immunological Aging</article-title>
<source/>Reference Module in Biomedical Sciences
          <publisher-name>Elsevier</publisher-name>
<publisher-loc>London, UK</publisher-loc>
<year>2015</year>
</element-citation>
</ref>
<ref id="B27-ijms-21-05094">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elwenspoek</surname>
<given-names>M.M.C.</given-names>
</name>
<name>
<surname>Sias</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hengesch</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Schaan</surname>
<given-names>V.K.</given-names>
</name>
<name>
<surname>Leenen</surname>
<given-names>F.A.D.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>MÃ©riaux</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Schmitz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bonnemberger</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ewen</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>T Cell Immunosenescence after Early Life Adversity: Association with Cytomegalovirus Infection</article-title>
<source/>Front. Immunol.
          <year>2017</year>
<volume>8</volume>
<fpage>1263</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2017.01263</pub-id>
<pub-id pub-id-type="pmid">29089944</pub-id>
</element-citation>
</ref>
<ref id="B28-ijms-21-05094">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elwenspoek</surname>
<given-names>M.M.C.</given-names>
</name>
<name>
<surname>Hengesch</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Leenen</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Schritz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sias</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schaan</surname>
<given-names>V.K.</given-names>
</name>
<name>
<surname>MÃ©riaux</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Schmitz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bonnemberger</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>SchÃ¤chinger</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Proinflammatory T Cell Status Associated with Early Life Adversity</article-title>
<source/>J. Immunol.
          <year>2017</year>
<volume>199</volume>
<fpage>4046</fpage>
<lpage>4055</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1701082</pub-id>
<pub-id pub-id-type="pmid">29133294</pub-id>
</element-citation>
</ref>
<ref id="B29-ijms-21-05094">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reid</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Sheerar</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Slukvina</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Donzella</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gunnar</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Persistent skewing of the T-cell profile in adolescents adopted internationally from institutional care</article-title>
<source/>Brain Behav. Immun.
          <year>2019</year>
<volume>77</volume>
<fpage>168</fpage>
<lpage>177</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2019.01.001</pub-id>
<pub-id pub-id-type="pmid">30639443</pub-id>
</element-citation>
</ref>
<ref id="B30-ijms-21-05094">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bendix</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rask</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rod</surname>
<given-names>N.H.</given-names>
</name>
</person-group>
<article-title>Stressful life events and leucocyte telomere length: Do lifestyle factors, somatic and mental health, or low grade inflammation mediate this relationship? Results from a cohort of Danish men born in 1953</article-title>
<source/>Brain Behav. Immun.
          <year>2016</year>
<volume>58</volume>
<fpage>248</fpage>
<lpage>253</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2016.07.154</pub-id>
<pub-id pub-id-type="pmid">27470228</pub-id>
</element-citation>
</ref>
<ref id="B31-ijms-21-05094">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaakxs</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wielaard</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>E Verhoeven</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Beekman</surname>
<given-names>A.T.F.</given-names>
</name>
<name>
<surname>Penninx</surname>
<given-names>B.W.J.H.</given-names>
</name>
<name>
<surname>Comijs</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>Early and recent psychosocial stress and telomere length in older adults</article-title>
<source/>Int. Psychogeriatr.
          <year>2015</year>
<volume>28</volume>
<fpage>405</fpage>
<lpage>413</lpage>
<pub-id pub-id-type="doi">10.1017/S1041610215001155</pub-id>
<pub-id pub-id-type="pmid">26265356</pub-id>
</element-citation>
</ref>
<ref id="B32-ijms-21-05094">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Ockenburg</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bos</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>De Jonge</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Van Der Harst</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gans</surname>
<given-names>R.O.B.</given-names>
</name>
<name>
<surname>Rosmalen</surname>
<given-names>J.G.</given-names>
</name>
</person-group>
<article-title>Stressful life events and leukocyte telomere attrition in adulthood: A prospective population-based cohort study</article-title>
<source/>Psychol. Med.
          <year>2015</year>
<volume>45</volume>
<fpage>2975</fpage>
<lpage>2984</lpage>
<pub-id pub-id-type="doi">10.1017/S0033291715000914</pub-id>
<pub-id pub-id-type="pmid">26219269</pub-id>
</element-citation>
</ref>
<ref id="B33-ijms-21-05094">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>RÃ©vÃ©sz</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Milaneschi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Terpstra</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Penninx</surname>
<given-names>B.W.</given-names>
</name>
</person-group>
<article-title>Baseline biopsychosocial determinants of telomere length and 6-year attrition rate</article-title>
<source/>Psychoneuroendocrinology
          <year>2016</year>
<volume>67</volume>
<fpage>153</fpage>
<lpage>162</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2016.02.007</pub-id>
<pub-id pub-id-type="pmid">26897704</pub-id>
</element-citation>
</ref>
<ref id="B34-ijms-21-05094">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elwenspoek</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Kuehn</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>The effects of early life adversity on the immune system</article-title>
<source/>Psychoneuroendocrinology
          <year>2017</year>
<volume>82</volume>
<fpage>140</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2017.05.012</pub-id>
<pub-id pub-id-type="pmid">28549270</pub-id>
</element-citation>
</ref>
<ref id="B35-ijms-21-05094">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Janicki-Deverts</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Marsland</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Casselbrant</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Li-Korotky</surname>
<given-names>H.-S.</given-names>
</name>
<name>
<surname>Epel</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>W.J.</given-names>
</name>
</person-group>
<article-title>Childhood socioeconomic status, telomere length, and susceptibility to upper respiratory infection</article-title>
<source/>Brain Behav. Immun.
          <year>2013</year>
<volume>34</volume>
<fpage>31</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2013.06.009</pub-id>
<pub-id pub-id-type="pmid">23845919</pub-id>
</element-citation>
</ref>
<ref id="B36-ijms-21-05094">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roque</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mesquita</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Palha</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Correia-Neves</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The Behavioral and Immunological Impact of Maternal Separation: A Matter of Timing</article-title>
<source/>Front. Behav. Neurosci.
          <year>2014</year>
<volume>8</volume>
<fpage>192</fpage>
<pub-id pub-id-type="doi">10.3389/fnbeh.2014.00192</pub-id>
<pub-id pub-id-type="pmid">24904343</pub-id>
</element-citation>
</ref>
<ref id="B37-ijms-21-05094">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silverman</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Pearce</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Biron</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>A.H.</given-names>
</name>
</person-group>
<article-title>Immune Modulation of the Hypothalamic-Pituitary-Adrenal (HPA) Axis during Viral Infection</article-title>
<source/>Viral Immunol.
          <year>2005</year>
<volume>18</volume>
<fpage>41</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1089/vim.2005.18.41</pub-id>
<pub-id pub-id-type="pmid">15802953</pub-id>
</element-citation>
</ref>
<ref id="B38-ijms-21-05094">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bailey</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Engler</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hunzeker</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sheridan</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>The Hypothalamic-Pituitary-Adrenal Axis and Viral Infection</article-title>
<source/>Viral Immunol.
          <year>2003</year>
<volume>16</volume>
<fpage>141</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1089/088282403322017884</pub-id>
<pub-id pub-id-type="pmid">12828866</pub-id>
</element-citation>
</ref>
<ref id="B39-ijms-21-05094">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Vaidyanathan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Annicelli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ip</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Medzhitov</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Long-Term Programming of CD8 T Cell Immunity by Perinatal Exposure to Glucocorticoids</article-title>
<source/>Cell
          <year>2020</year>
<volume>180</volume>
<fpage>847</fpage>
<lpage>861</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2020.02.018</pub-id>
<pub-id pub-id-type="pmid">32142678</pub-id>
</element-citation>
</ref>
<ref id="B40-ijms-21-05094">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elwenspoek</surname>
<given-names>M.M.C.</given-names>
</name>
<name>
<surname>Hengesch</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Leenen</surname>
<given-names>F.A.D.</given-names>
</name>
<name>
<surname>Sias</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Schaan</surname>
<given-names>V.K.</given-names>
</name>
<name>
<surname>MÃ©riaux</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Schmitz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bonnemberger</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>SchÃ¤chinger</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Glucocorticoid receptor signaling in leukocytes after early life adversity</article-title>
<source/>Dev. Psychopathol.
          <year>2019</year>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1017/S0954579419001147</pub-id>
</element-citation>
</ref>
<ref id="B41-ijms-21-05094">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stoll</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fanaroff</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Carlo</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Ehrenkranz</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Lemons</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Donovan</surname>
<given-names>E.F.</given-names>
</name>
<name>
<surname>Stark</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Tyson</surname>
<given-names>J.E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Changes in Pathogens Causing Early-Onset Sepsis in Very-Low-Birth-Weight Infants</article-title>
<source/>N. Engl. J. Med.
          <year>2002</year>
<volume>347</volume>
<fpage>240</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa012657</pub-id>
<pub-id pub-id-type="pmid">12140299</pub-id>
</element-citation>
</ref>
<ref id="B42-ijms-21-05094">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>AlShaikh</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yusuf</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sauve</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Neurodevelopmental outcomes of very low birth weight infants with neonatal sepsis: Systematic review and meta-analysis</article-title>
<source/>J. Perinatol.
          <year>2013</year>
<volume>33</volume>
<fpage>558</fpage>
<lpage>564</lpage>
<pub-id pub-id-type="doi">10.1038/jp.2012.167</pub-id>
<pub-id pub-id-type="pmid">23328927</pub-id>
</element-citation>
</ref>
<ref id="B43-ijms-21-05094">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bilbo</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Schwarz</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Early-life programming of later-life brain and behavior: A critical role for the immune system</article-title>
<source/>Front. Behav. Neurosci.
          <year>2009</year>
<volume>3</volume>
<fpage>14</fpage>
<pub-id pub-id-type="doi">10.3389/neuro.08.014.2009</pub-id>
<pub-id pub-id-type="pmid">19738918</pub-id>
</element-citation>
</ref>
<ref id="B44-ijms-21-05094">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cornet</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Douxfils</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mandiki</surname>
<given-names>S.N.</given-names>
</name>
<name>
<surname>Kestemont</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Early-life infection with a bacterial pathogen increases expression levels of innate immunity related genes during adulthood in zebrafish</article-title>
<source/>Dev. Comp. Immunol.
          <year>2020</year>
<volume>108</volume>
<fpage>103672</fpage>
<pub-id pub-id-type="doi">10.1016/j.dci.2020.103672</pub-id>
<pub-id pub-id-type="pmid">32151677</pub-id>
</element-citation>
</ref>
<ref id="B45-ijms-21-05094">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez</surname>
<given-names>F.D.</given-names>
</name>
</person-group>
<article-title>Viruses and Atopic Sensitization in the First Years of Life</article-title>
<source/>Am. J. Respir. Crit. Care Med.
          <year>2000</year>
<volume>162</volume>
<fpage>S95</fpage>
<lpage>S99</lpage>
<pub-id pub-id-type="doi">10.1164/ajrccm.162.supplement_2.ras-8</pub-id>
<pub-id pub-id-type="pmid">10988160</pub-id>
</element-citation>
</ref>
<ref id="B46-ijms-21-05094">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Townsi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Laing</surname>
<given-names>I.A.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>G.L.</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The impact of respiratory viruses on lung health after preterm birth</article-title>
<source/>Eur. Clin. Respir. J.
          <year>2018</year>
<volume>5</volume>
<fpage>1487214</fpage>
<pub-id pub-id-type="doi">10.1080/20018525.2018.1487214</pub-id>
<pub-id pub-id-type="pmid">30128088</pub-id>
</element-citation>
</ref>
<ref id="B47-ijms-21-05094">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malinczak</surname>
<given-names>C.-A.</given-names>
</name>
<name>
<surname>Lukacs</surname>
<given-names>N.W.</given-names>
</name>
<name>
<surname>Fonseca</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Early-Life Respiratory Syncytial Virus Infection, Trained Immunity and Subsequent Pulmonary Diseases</article-title>
<source/>Viruses
          <year>2020</year>
<volume>12</volume>
<elocation-id>505</elocation-id>
<pub-id pub-id-type="doi">10.3390/v12050505</pub-id>
</element-citation>
</ref>
<ref id="B48-ijms-21-05094">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beyerlein</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Donnachie</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Jergens</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ziegler</surname>
<given-names>A.-G.</given-names>
</name>
</person-group>
<article-title>Infections in Early Life and Development of Type 1 Diabetes</article-title>
<source/>JAMA
          <year>2016</year>
<volume>315</volume>
<fpage>1899</fpage>
<pub-id pub-id-type="doi">10.1001/jama.2016.2181</pub-id>
<pub-id pub-id-type="pmid">27139064</pub-id>
</element-citation>
</ref>
<ref id="B49-ijms-21-05094">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fonseca</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Malinczak</surname>
<given-names>C.-A.</given-names>
</name>
<name>
<surname>Schuler</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Best</surname>
<given-names>S.K.K.</given-names>
</name>
<name>
<surname>Rasky</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>T.X.</given-names>
</name>
<name>
<surname>Popova</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Lukacs</surname>
<given-names>N.W.</given-names>
</name>
</person-group>
<article-title>Uric acid pathway activation during respiratory virus infection promotes Th2 immune response via innate cytokine production and ILC2 accumulation</article-title>
<source/>Mucosal Immunol.
          <year>2020</year>
<volume>13</volume>
<fpage>691</fpage>
<lpage>701</lpage>
<pub-id pub-id-type="doi">10.1038/s41385-020-0264-z</pub-id>
<pub-id pub-id-type="pmid">32047272</pub-id>
</element-citation>
</ref>
<ref id="B50-ijms-21-05094">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hart</surname>
<given-names>B.L.</given-names>
</name>
</person-group>
<article-title>Biological basis of the behavior of sick animals</article-title>
<source/>Neurosci. Biobehav. Rev.
          <year>1988</year>
<volume>12</volume>
<fpage>123</fpage>
<lpage>137</lpage>
<pub-id pub-id-type="doi">10.1016/S0149-7634(88)80004-6</pub-id>
<pub-id pub-id-type="pmid">3050629</pub-id>
</element-citation>
</ref>
<ref id="B51-ijms-21-05094">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wampach</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Heintz-Buschart</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fritz</surname>
<given-names>J.V.</given-names>
</name>
<name>
<surname>Ramiro-Garcia</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Habier</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Herold</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Narayanasamy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kaysen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Bindl</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Birth mode is associated with earliest strain-conferred gut microbiome functions and immunostimulatory potential</article-title>
<source/>Nat. Commun.
          <year>2018</year>
<volume>9</volume>
<fpage>5091</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-018-07631-x</pub-id>
<pub-id pub-id-type="pmid">30504906</pub-id>
</element-citation>
</ref>
<ref id="B52-ijms-21-05094">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Forster</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Tsaliki</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Vervier</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Strang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Stares</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Rodger</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Brocklehurst</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth</article-title>
<source/>Nature
          <year>2019</year>
<volume>574</volume>
<fpage>117</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-019-1560-1</pub-id>
<pub-id pub-id-type="pmid">31534227</pub-id>
</element-citation>
</ref>
<ref id="B53-ijms-21-05094">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>More than 9,000,000 Unique Genes in Human Gut Bacterial Community: Estimating Gene Numbers Inside a Human Body</article-title>
<source/>PLoS ONE
          <year>2009</year>
<volume>4</volume>
<elocation-id>e6074</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0006074</pub-id>
<pub-id pub-id-type="pmid">19562079</pub-id>
</element-citation>
</ref>
<ref id="B54-ijms-21-05094">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Alammar</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nanavati</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chaudhary</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mullin</surname>
<given-names>G.E.</given-names>
</name>
</person-group>
<article-title>Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies</article-title>
<source/>J. Acad. Nutr. Diet.
          <year>2020</year>
<volume>120</volume>
<fpage>565</fpage>
<lpage>586</lpage>
<pub-id pub-id-type="doi">10.1016/j.jand.2019.05.015</pub-id>
<pub-id pub-id-type="pmid">31473156</pub-id>
</element-citation>
</ref>
<ref id="B55-ijms-21-05094">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogers</surname>
<given-names>G.B.</given-names>
</name>
<name>
<surname>Keating</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>M.-L.</given-names>
</name>
<name>
<surname>Licinio</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wesselingh</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>From gut dysbiosis to altered brain function and mental illness: Mechanisms and pathways</article-title>
<source/>Mol. Psychiatry
          <year>2016</year>
<volume>21</volume>
<fpage>738</fpage>
<lpage>748</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2016.50</pub-id>
<pub-id pub-id-type="pmid">27090305</pub-id>
</element-citation>
</ref>
<ref id="B56-ijms-21-05094">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zijlmans</surname>
<given-names>M.A.C.</given-names>
</name>
<name>
<surname>Korpela</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Riksen-Walraven</surname>
<given-names>J.M.A.</given-names>
</name>
<name>
<surname>De Vos</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>De Weerth</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Maternal prenatal stress is associated with the infant intestinal microbiota</article-title>
<source/>Psychoneuroendocrinology
          <year>2015</year>
<volume>53</volume>
<fpage>233</fpage>
<lpage>245</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2015.01.006</pub-id>
<pub-id pub-id-type="pmid">25638481</pub-id>
</element-citation>
</ref>
<ref id="B57-ijms-21-05094">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Shalowitz</surname>
<given-names>M.U.</given-names>
</name>
<name>
<surname>Story</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Leigh</surname>
<given-names>A.K.K.</given-names>
</name>
<name>
<surname>Ham</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ba</surname>
<given-names>J.M.G.A.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>S.W.</given-names>
</name>
</person-group>
<article-title>Divergent transcriptional profiles in pediatric asthma patients of low and high socioeconomic status</article-title>
<source/>Pediatr. Pulmonol.
          <year>2018</year>
<volume>53</volume>
<fpage>710</fpage>
<lpage>719</lpage>
<pub-id pub-id-type="doi">10.1002/ppul.23983</pub-id>
<pub-id pub-id-type="pmid">29528197</pub-id>
</element-citation>
</ref>
<ref id="B58-ijms-21-05094">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quilliam</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Weidmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Moresco</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Purshouse</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>OâHara</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Oliver</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>COVID-19: The environmental implications of shedding SARS-CoV-2 in human faeces</article-title>
<source/>Environ. Int.
          <year>2020</year>
<volume>140</volume>
<fpage>105790</fpage>
<pub-id pub-id-type="doi">10.1016/j.envint.2020.105790</pub-id>
<pub-id pub-id-type="pmid">32388248</pub-id>
</element-citation>
</ref>
<ref id="B59-ijms-21-05094">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heller</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mota</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Greco</surname>
<given-names>D.B.</given-names>
</name>
</person-group>
<article-title>COVID-19 faecal-oral transmission: Are we asking the right questions?</article-title>
<source/>Sci. Total Environ.
          <year>2020</year>
<volume>729</volume>
<fpage>138919</fpage>
<pub-id pub-id-type="doi">10.1016/j.scitotenv.2020.138919</pub-id>
<pub-id pub-id-type="pmid">32353720</pub-id>
</element-citation>
</ref>
<ref id="B60-ijms-21-05094">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DâAmico</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Baumgart</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Danese</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Peyrin-Biroulet</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management</article-title>
<source/>Clin. Gastroenterol. Hepatol.
          <year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.cgh.2020.04.001</pub-id>
</element-citation>
</ref>
<ref id="B61-ijms-21-05094">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torow</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hornef</surname>
<given-names>M.W.</given-names>
</name>
</person-group>
<article-title>The Neonatal Window of Opportunity: Setting the Stage for Life-Long Host-Microbial Interaction and Immune Homeostasis</article-title>
<source/>J. Immunol.
          <year>2017</year>
<volume>198</volume>
<fpage>557</fpage>
<lpage>563</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1601253</pub-id>
<pub-id pub-id-type="pmid">28069750</pub-id>
</element-citation>
</ref>
<ref id="B62-ijms-21-05094">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keag</surname>
<given-names>O.E.</given-names>
</name>
<name>
<surname>E Norman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Stock</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Long-term risks and benefits associated with cesarean delivery for mother, baby, and subsequent pregnancies: Systematic review and meta-analysis</article-title>
<source/>PLoS Med.
          <year>2018</year>
<volume>15</volume>
<elocation-id>e1002494</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pmed.1002494</pub-id>
<pub-id pub-id-type="pmid">29360829</pub-id>
</element-citation>
</ref>
<ref id="B63-ijms-21-05094">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wesemann</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Portuguese</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Meyers</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Cluff-Jones</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Magee</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Panchakshari</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Rodig</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Kepler</surname>
<given-names>T.B.</given-names>
</name>
<name>
<surname>Alt</surname>
<given-names>F.W.</given-names>
</name>
</person-group>
<article-title>Microbial colonization influences early B-lineage development in the gut lamina propria</article-title>
<source/>Nature
          <year>2013</year>
<volume>501</volume>
<fpage>112</fpage>
<lpage>115</lpage>
<pub-id pub-id-type="doi">10.1038/nature12496</pub-id>
<pub-id pub-id-type="pmid">23965619</pub-id>
</element-citation>
</ref>
<ref id="B64-ijms-21-05094">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cahenzli</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>KÃ¶ller</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wyss</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Geuking</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>McCoy</surname>
<given-names>K.D.</given-names>
</name>
</person-group>
<article-title>Intestinal microbial diversity during early-life colonization shapes long-term IgE levels</article-title>
<source/>Cell Host Microbe
          <year>2013</year>
<volume>14</volume>
<fpage>559</fpage>
<lpage>570</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2013.10.004</pub-id>
<pub-id pub-id-type="pmid">24237701</pub-id>
</element-citation>
</ref>
<ref id="B65-ijms-21-05094">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lathrop</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Bloom</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Nutsch</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lio</surname>
<given-names>C.-W.</given-names>
</name>
<name>
<surname>Santacruz</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Stappenbeck</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>C.-S.</given-names>
</name>
</person-group>
<article-title>Peripheral education of the immune system by colonic commensal microbiota</article-title>
<source/>Nature
          <year>2011</year>
<volume>478</volume>
<fpage>250</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1038/nature10434</pub-id>
<pub-id pub-id-type="pmid">21937990</pub-id>
</element-citation>
</ref>
<ref id="B66-ijms-21-05094">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cebula</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Seweryn</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rempala</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Pabla</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>McIndoe</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Denning</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Bry</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kraj</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kisielow</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ignatowicz</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota</article-title>
<source/>Nature
          <year>2013</year>
<volume>497</volume>
<fpage>258</fpage>
<lpage>262</lpage>
<pub-id pub-id-type="doi">10.1038/nature12079</pub-id>
<pub-id pub-id-type="pmid">23624374</pub-id>
</element-citation>
</ref>
<ref id="B67-ijms-21-05094">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaboriau-Routhiau</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Rakotobe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lecuyer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mulder</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bridonneau</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rochet</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Pisi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>De Paepe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brandi</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Key Role of Segmented Filamentous Bacteria in the Coordinated Maturation of Gut Helper T Cell Responses</article-title>
<source/>Immunity
          <year>2009</year>
<volume>31</volume>
<fpage>677</fpage>
<lpage>689</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2009.08.020</pub-id>
<pub-id pub-id-type="pmid">19833089</pub-id>
</element-citation>
</ref>
<ref id="B68-ijms-21-05094">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herzog</surname>
<given-names>J.I.</given-names>
</name>
<name>
<surname>Schmahl</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Adverse Childhood Experiences and the Consequences on Neurobiological, Psychosocial, and Somatic Conditions Across the Lifespan</article-title>
<source/>Front. Psychol.
          <year>2018</year>
<volume>9</volume>
<fpage>420</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyt.2018.00420</pub-id>
<pub-id pub-id-type="pmid">29643827</pub-id>
</element-citation>
</ref>
<ref id="B69-ijms-21-05094">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gostic</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Bridge</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Brady</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Viboud</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Worobey</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lloyd-Smith</surname>
<given-names>J.O.</given-names>
</name>
</person-group>
<article-title>Childhood immune imprinting to influenza A shapes birth year-specific risk during seasonal H1N1 and H3N2 epidemics</article-title>
<source/>PLoS Pathog.
          <year>2019</year>
<volume>15</volume>
<elocation-id>e1008109</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1008109</pub-id>
<pub-id pub-id-type="pmid">31856206</pub-id>
</element-citation>
</ref>
<ref id="B70-ijms-21-05094">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hashimoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Perlot</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rehman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Trichereau</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ishiguro</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Paolino</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sigl</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Hanada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hanada</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lipinski</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation</article-title>
<source/>Nature
          <year>2012</year>
<volume>487</volume>
<fpage>477</fpage>
<lpage>481</lpage>
<pub-id pub-id-type="doi">10.1038/nature11228</pub-id>
<pub-id pub-id-type="pmid">22837003</pub-id>
</element-citation>
</ref>
<ref id="B71-ijms-21-05094">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vuille-Dit-Bille</surname>
<given-names>R.N.</given-names>
</name>
<name>
<surname>Camargo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Emmenegger</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sasse</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kummer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Jando</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hamie</surname>
<given-names>Q.M.</given-names>
</name>
<name>
<surname>Meier</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Hunziker</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Forras-Kaufmann</surname>
<given-names>Z.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors</article-title>
<source/>Amino Acids
          <year>2014</year>
<volume>47</volume>
<fpage>693</fpage>
<lpage>705</lpage>
<pub-id pub-id-type="doi">10.1007/s00726-014-1889-6</pub-id>
<pub-id pub-id-type="pmid">25534429</pub-id>
</element-citation>
</ref>
<ref id="B72-ijms-21-05094">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wlodarska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kostic</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Xavier</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>An Integrative View of Microbiome-Host Interactions in Inflammatory Bowel Diseases</article-title>
<source/>Cell Host Microbe
          <year>2015</year>
<volume>17</volume>
<fpage>577</fpage>
<lpage>591</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2015.04.008</pub-id>
<pub-id pub-id-type="pmid">25974300</pub-id>
</element-citation>
</ref>
<ref id="B73-ijms-21-05094">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study</article-title>
<source/>PLoS ONE
          <year>2020</year>
<volume>15</volume>
<elocation-id>e0230295</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0230295</pub-id>
<pub-id pub-id-type="pmid">32298273</pub-id>
</element-citation>
</ref>
<ref id="B74-ijms-21-05094">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Infection of bat and human intestinal organoids by SARS-CoV-2</article-title>
<source/>Nat. Med.
          <year>2020</year>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1038/s41591-020-0912-6</pub-id>
<pub-id pub-id-type="pmid">31932805</pub-id>
</element-citation>
</ref>
<ref id="B75-ijms-21-05094">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vecoli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pulignani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Andreassi</surname>
<given-names>M.G.</given-names>
</name>
</person-group>
<article-title>Genetic and Epigenetic Mechanisms Linking Air Pollution and Congenital Heart Disease</article-title>
<source/>J. Cardiovasc. Dev. Dis.
          <year>2016</year>
<volume>3</volume>
<elocation-id>32</elocation-id>
<pub-id pub-id-type="doi">10.3390/jcdd3040032</pub-id>
<pub-id pub-id-type="pmid">29367575</pub-id>
</element-citation>
</ref>
<ref id="B76-ijms-21-05094">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rider</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Carlsten</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Air pollution and DNA methylation: Effects of exposure in humans</article-title>
<source/>Clin. Epigenetics
          <year>2019</year>
<volume>11</volume>
<fpage>131</fpage>
<pub-id pub-id-type="doi">10.1186/s13148-019-0713-2</pub-id>
<pub-id pub-id-type="pmid">31481107</pub-id>
</element-citation>
</ref>
<ref id="B77-ijms-21-05094">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L.-F.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Air pollutants and early origins of respiratory diseases</article-title>
<source/>Chronic Dis. Transl. Med.
          <year>2018</year>
<volume>4</volume>
<fpage>75</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1016/j.cdtm.2018.03.003</pub-id>
<pub-id pub-id-type="pmid">29988883</pub-id>
</element-citation>
</ref>
<ref id="B78-ijms-21-05094">
<label>78.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Gurjar</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Molina</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ojha</surname>
<given-names>C.S.P.</given-names>
</name>
</person-group>
<source/>Air Pollution Health and environmental Impacts
          <publisher-name>CRC Press</publisher-name>
<publisher-loc>Boca Raton, FA, USA</publisher-loc>
<year>2010</year>
<fpage>556</fpage>
</element-citation>
</ref>
<ref id="B79-ijms-21-05094">
<label>79.</label>
<element-citation publication-type="book">
<source/>Report of the Task Group on Reference Man: A Report
          <publisher-name>Pergamon Press</publisher-name>
<publisher-loc>Oxford, UK</publisher-loc>
<publisher-loc>Toronto, ON, Canada</publisher-loc>
<year>1975</year>
</element-citation>
</ref>
<ref id="B80-ijms-21-05094">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Association between short-term exposure to air pollution and COVID-19 infection: Evidence from China</article-title>
<source/>Sci. Total Environ.
          <year>2020</year>
<volume>727</volume>
<fpage>138704</fpage>
<pub-id pub-id-type="doi">10.1016/j.scitotenv.2020.138704</pub-id>
<pub-id pub-id-type="pmid">32315904</pub-id>
</element-citation>
</ref>
<ref id="B81-ijms-21-05094">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martelletti</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Martelletti</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Air Pollution and the Novel Covid-19 Disease: A Putative Disease Risk Factor</article-title>
<source/>SN Compr. Clin. Med.
          <year>2020</year>
<volume>2</volume>
<fpage>383</fpage>
<lpage>387</lpage>
<pub-id pub-id-type="doi">10.1007/s42399-020-00274-4</pub-id>
</element-citation>
</ref>
<ref id="B82-ijms-21-05094">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Setti</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Passarini</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>De Gennaro</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Baribieri</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Perrone</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Borelli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Palmisani</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Di Gilio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Torboli</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Pallavicini</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SARS-Cov-2 RNA Found on Particulate Matter of Bergamo in Northern Italy: First Preliminary Evidence</article-title>
<source/>First Preliminary Evidence. medRxiv
          <year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.04.15.20065995</pub-id>
</element-citation>
</ref>
<ref id="B83-ijms-21-05094">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Nethery</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Sabath</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Braun</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dominici</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Exposure to air pollution and COVID-19 mortality in the United States: A nationwide cross-sectional study</article-title>
<source/>medRxiv
          <year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.04.05.20054502</pub-id>
</element-citation>
</ref>
<ref id="B84-ijms-21-05094">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huxley</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Neil</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Unravelling the fetal origins hypothesis: Is there really an inverse association between birthweight and subsequent blood pressure?</article-title>
<source/>Lancet
          <year>2002</year>
<volume>360</volume>
<fpage>659</fpage>
<lpage>665</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(02)09834-3</pub-id>
<pub-id pub-id-type="pmid">12241871</pub-id>
</element-citation>
</ref>
<ref id="B85-ijms-21-05094">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Djp</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Early growth and cardiovascular disease</article-title>
<source/>Arch. Dis. Child.
          <year>1999</year>
<volume>80</volume>
<fpage>305</fpage>
<lpage>307</lpage>
<pub-id pub-id-type="doi">10.1136/adc.80.4.305</pub-id>
<pub-id pub-id-type="pmid">10086930</pub-id>
</element-citation>
</ref>
<ref id="B86-ijms-21-05094">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calkins</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Devaskar</surname>
<given-names>S.U.</given-names>
</name>
</person-group>
<article-title>Fetal origins of adult disease</article-title>
<source/>Curr. Probl. Pediatr. Adolesc. Health Care
          <year>2011</year>
<volume>41</volume>
<fpage>158</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="doi">10.1016/j.cppeds.2011.01.001</pub-id>
<pub-id pub-id-type="pmid">21684471</pub-id>
</element-citation>
</ref>
<ref id="B87-ijms-21-05094">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ceriello</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stoian</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Rizzo</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>COVID-19 and diabetes management: What should be considered?</article-title>
<source/>Diabetes Res. Clin. Pract.
          <year>2020</year>
<volume>163</volume>
<fpage>108151</fpage>
<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108151</pub-id>
<pub-id pub-id-type="pmid">32305399</pub-id>
</element-citation>
</ref>
<ref id="B88-ijms-21-05094">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iacobellis</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>COVID-19 and diabetes: Can DPP4 inhibition play a role?</article-title>
<source/>Diabetes Res. Clin. Pract.
          <year>2020</year>
<volume>162</volume>
<fpage>108125</fpage>
<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108125</pub-id>
<pub-id pub-id-type="pmid">32224164</pub-id>
</element-citation>
</ref>
<ref id="B89-ijms-21-05094">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>X.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study</article-title>
<source/>Lancet
          <year>2020</year>
<volume>395</volume>
<fpage>1054</fpage>
<lpage>1062</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30566-3</pub-id>
<pub-id pub-id-type="pmid">32171076</pub-id>
</element-citation>
</ref>
<ref id="B90-ijms-21-05094">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turner</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Holistic, personalized, immunology? The effects of socioeconomic status on the transcriptional milieu of immune cells</article-title>
<source/>Pediatr. Pulmonol.
          <year>2018</year>
<volume>53</volume>
<fpage>696</fpage>
<lpage>697</lpage>
<pub-id pub-id-type="doi">10.1002/ppul.23986</pub-id>
<pub-id pub-id-type="pmid">29667347</pub-id>
</element-citation>
</ref>
<ref id="B91-ijms-21-05094">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peric</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stulnig</surname>
<given-names>T.M.</given-names>
</name>
</person-group>
<article-title>Diabetes and COVID-19</article-title>
<source/>Wien. Klin. Wochenschr.
          <year>2020</year>
<fpage>1</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1007/s00508-020-01672-3</pub-id>
<pub-id pub-id-type="pmid">31912289</pub-id>
</element-citation>
</ref>
<ref id="B92-ijms-21-05094">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kleine-Weber</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Schroeder</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>KrÃ¼ger</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Herrler</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Erichsen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schiergens</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Herrler</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>N.-H.</given-names>
</name>
<name>
<surname>Nitsche</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor</article-title>
<source/>Cell
          <year>2020</year>
<volume>181</volume>
<fpage>271</fpage>
<lpage>280</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2020.02.052</pub-id>
<pub-id pub-id-type="pmid">32142651</pub-id>
</element-citation>
</ref>
<ref id="B93-ijms-21-05094">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Riera</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Palau</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Pascual</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Soler</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse</article-title>
<source/>Int. J. Mol. Sci.
          <year>2017</year>
<volume>18</volume>
<elocation-id>563</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms18030563</pub-id>
</element-citation>
</ref>
<ref id="B94-ijms-21-05094">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pal</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bhadada</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?</article-title>
<source/>Diabetes Res. Clin. Pract.
          <year>2020</year>
<volume>163</volume>
<fpage>108146</fpage>
<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108146</pub-id>
<pub-id pub-id-type="pmid">32283128</pub-id>
</element-citation>
</ref>
<ref id="B95-ijms-21-05094">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ceriello</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory</article-title>
<source/>Diabetes Res. Clin. Pract.
          <year>2020</year>
<volume>163</volume>
<fpage>108186</fpage>
<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108186</pub-id>
<pub-id pub-id-type="pmid">32360400</pub-id>
</element-citation>
</ref>
<ref id="B96-ijms-21-05094">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussain</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bhowmik</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Moreira</surname>
<given-names>N.C.D.V.</given-names>
</name>
</person-group>
<article-title>COVID-19 and diabetes: Knowledge in progress</article-title>
<source/>Diabetes Res. Clin. Pract.
          <year>2020</year>
<volume>162</volume>
<fpage>108142</fpage>
<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108142</pub-id>
<pub-id pub-id-type="pmid">32278764</pub-id>
</element-citation>
</ref>
<ref id="B97-ijms-21-05094">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hostinar</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>G.E.</given-names>
</name>
</person-group>
<article-title>Early-Life Socioeconomic Disadvantage and Metabolic Health Disparities</article-title>
<source/>Psychosom. Med.
          <year>2017</year>
<volume>79</volume>
<fpage>514</fpage>
<lpage>523</lpage>
<pub-id pub-id-type="doi">10.1097/PSY.0000000000000455</pub-id>
<pub-id pub-id-type="pmid">28178032</pub-id>
</element-citation>
</ref>
<ref id="B98-ijms-21-05094">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horner</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Strombotne</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lapham</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Investigating the Early Life Determinants of Type-II Diabetes Using a Project Talent-Medicare Linked Data-set</article-title>
<source/>SSM Popul. Health
          <year>2018</year>
<volume>4</volume>
<fpage>189</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="doi">10.1016/j.ssmph.2018.01.004</pub-id>
<pub-id pub-id-type="pmid">29854904</pub-id>
</element-citation>
</ref>
<ref id="B99-ijms-21-05094">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chandan</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Okoth</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gokhale</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Bandyopadhyay</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nirantharakumar</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Increased Cardiometabolic and Mortality Risk Following Childhood Maltreatment in the United Kingdom</article-title>
<source/>J. Am. Heart Assoc.
          <year>2020</year>
<volume>9</volume>
<fpage>e015855</fpage>
<pub-id pub-id-type="doi">10.1161/JAHA.119.015855</pub-id>
<pub-id pub-id-type="pmid">32410481</pub-id>
</element-citation>
</ref>
<ref id="B100-ijms-21-05094">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Needham</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kardia</surname>
<given-names>S.L.R.</given-names>
</name>
<name>
<surname>Shively</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Seeman</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Roux</surname>
<given-names>A.V.D.</given-names>
</name>
</person-group>
<article-title>Life course socioeconomic status and DNA methylation in genes related to stress reactivity and inflammation: The multi-ethnic study of atherosclerosis</article-title>
<source/>Epigenetics
          <year>2015</year>
<volume>10</volume>
<fpage>958</fpage>
<lpage>969</lpage>
<pub-id pub-id-type="doi">10.1080/15592294.2015.1085139</pub-id>
<pub-id pub-id-type="pmid">26295359</pub-id>
</element-citation>
</ref>
<ref id="B101-ijms-21-05094">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jackson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Marks</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>May</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>J.B.</given-names>
</name>
</person-group>
<article-title>The genetic basis of disease</article-title>
<source/>Essays Biochem.
          <year>2018</year>
<volume>62</volume>
<fpage>643</fpage>
<lpage>723</lpage>
<pub-id pub-id-type="doi">10.1042/EBC20170053</pub-id>
<pub-id pub-id-type="pmid">30509934</pub-id>
</element-citation>
</ref>
<ref id="B102-ijms-21-05094">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>M2-specific reduction of CD1d switches NKT cell-mediated immune responses and triggers metaflammation in adipose tissue</article-title>
<source/>Cell Mol. Immunol.
          <year>2017</year>
<volume>15</volume>
<fpage>506</fpage>
<lpage>517</lpage>
<pub-id pub-id-type="doi">10.1038/cmi.2017.11</pub-id>
<pub-id pub-id-type="pmid">28392574</pub-id>
</element-citation>
</ref>
<ref id="B103-ijms-21-05094">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Long</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Thorpe</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>DeBerg</surname>
<given-names>H.A.</given-names>
</name>
<name>
<surname>Gersuk</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Eddy</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Ehlers</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Herold</surname>
<given-names>K.C.</given-names>
</name>
<name>
<surname>Nepom</surname>
<given-names>G.T.</given-names>
</name>
<name>
<surname>Linsley</surname>
<given-names>P.S.</given-names>
</name>
</person-group>
<article-title>Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes</article-title>
<source/>Sci. Immunol.
          <year>2016</year>
<volume>1</volume>
<fpage>eaai7793</fpage>
<pub-id pub-id-type="doi">10.1126/sciimmunol.aai7793</pub-id>
<pub-id pub-id-type="pmid">28664195</pub-id>
</element-citation>
</ref>
<ref id="B104-ijms-21-05094">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Truax</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tam</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Koblansky</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>W.-C.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Brickey</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Petrucelli</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis</article-title>
<source/>Cell Host Microbe
          <year>2018</year>
<volume>24</volume>
<fpage>364</fpage>
<lpage>378.e6</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2018.08.009</pub-id>
<pub-id pub-id-type="pmid">30212649</pub-id>
</element-citation>
</ref>
<ref id="B105-ijms-21-05094">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Adhikarakunnathu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mateo</surname>
<given-names>L.R.S.</given-names>
</name>
<name>
<surname>Duffy</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Rafferty</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bugelski</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Deutsch</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Picha</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Loss of toll-like receptor 3 function improves glucose tolerance and reduces liver steatosis in obese mice</article-title>
<source/>Metabolism
          <year>2012</year>
<volume>61</volume>
<fpage>1633</fpage>
<lpage>1645</lpage>
<pub-id pub-id-type="doi">10.1016/j.metabol.2012.04.015</pub-id>
<pub-id pub-id-type="pmid">22607770</pub-id>
</element-citation>
</ref>
<ref id="B106-ijms-21-05094">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carroll</surname>
<given-names>H.A.</given-names>
</name>
<name>
<surname>James</surname>
<given-names>L.J.</given-names>
</name>
</person-group>
<article-title>Hydration, Arginine Vasopressin, and Glucoregulatory Health in Humans: A Critical Perspective</article-title>
<source/>Nutrure
          <year>2019</year>
<volume>11</volume>
<elocation-id>1201</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu11061201</pub-id>
</element-citation>
</ref>
<ref id="B107-ijms-21-05094">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sidibeh</surname>
<given-names>C.O.</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Abalo</surname>
<given-names>X.M.</given-names>
</name>
<name>
<surname>Boersma</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Skrtic</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lundkvist</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Katsogiannos</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hausch</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Castillejo-LÃ³pez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Eriksson</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<article-title>FKBP5 expression in human adipose tissue: Potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes</article-title>
<source/>Endocrine
          <year>2018</year>
<volume>62</volume>
<fpage>116</fpage>
<lpage>128</lpage>
<pub-id pub-id-type="doi">10.1007/s12020-018-1674-5</pub-id>
<pub-id pub-id-type="pmid">30032404</pub-id>
</element-citation>
</ref>
<ref id="B108-ijms-21-05094">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salonen</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Uimari</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Aalto</surname>
<given-names>J.-M.</given-names>
</name>
<name>
<surname>Pirskanen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kaikkonen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Todorova</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>HyppÃ¶nen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Korhonen</surname>
<given-names>V.-P.</given-names>
</name>
<name>
<surname>Asikainen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Devine</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Type 2 Diabetes Whole-Genome Association Study in Four Populations: The DiaGen Consortium</article-title>
<source/>Am. J. Hum. Genet.
          <year>2007</year>
<volume>81</volume>
<fpage>338</fpage>
<lpage>345</lpage>
<pub-id pub-id-type="doi">10.1086/520599</pub-id>
<pub-id pub-id-type="pmid">17668382</pub-id>
</element-citation>
</ref>
<ref id="B109-ijms-21-05094">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lau</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Callender</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Hood</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Berryman</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Pattrick</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Finer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>A Hitman</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ackland</surname>
<given-names>G.L.</given-names>
</name>
<name>
<surname>Henson</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Type 2 diabetes is associated with the accumulation of senescent T cells</article-title>
<source/>Clin. Exp. Immunol.
          <year>2019</year>
<volume>197</volume>
<fpage>205</fpage>
<lpage>213</lpage>
<pub-id pub-id-type="doi">10.1111/cei.13344</pub-id>
<pub-id pub-id-type="pmid">31251396</pub-id>
</element-citation>
</ref>
<ref id="B110-ijms-21-05094">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yi</surname>
<given-names>H.-S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.-S.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>Y.E.</given-names>
</name>
<name>
<surname>Joung</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>T-cell senescence contributes to abnormal glucose homeostasis in humans and mice</article-title>
<source/>Cell Death Dis.
          <year>2019</year>
<volume>10</volume>
<fpage>249</fpage>
<pub-id pub-id-type="doi">10.1038/s41419-019-1494-4</pub-id>
<pub-id pub-id-type="pmid">30867412</pub-id>
</element-citation>
</ref>
<ref id="B111-ijms-21-05094">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toniolo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cassani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Puggioni</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Colombo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Onodera</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ferrannini</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>The diabetes pandemic and associated infections</article-title>
<source/>Rev. Med. Microbiol.
          <year>2019</year>
<volume>30</volume>
<fpage>1</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1097/MRM.0000000000000155</pub-id>
<pub-id pub-id-type="pmid">30662163</pub-id>
</element-citation>
</ref>
<ref id="B112-ijms-21-05094">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thevarajan</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>T.H.O.</given-names>
</name>
<name>
<surname>Koutsakos</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Druce</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Caly</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Van De Sandt</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Nicholson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Catton</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cowie</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Breadth of concomitant immune responses prior to patient recovery: A case report of non-severe COVID-19</article-title>
<source/>Nat. Med.
          <year>2020</year>
<volume>26</volume>
<fpage>453</fpage>
<lpage>455</lpage>
<pub-id pub-id-type="doi">10.1038/s41591-020-0819-2</pub-id>
<pub-id pub-id-type="pmid">32284614</pub-id>
</element-citation>
</ref>
<ref id="B113-ijms-21-05094">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pathological findings of COVID-19 associated with acute respiratory distress syndrome</article-title>
<source/>Lancet Respir. Med.
          <year>2020</year>
<volume>8</volume>
<fpage>420</fpage>
<lpage>422</lpage>
<pub-id pub-id-type="doi">10.1016/S2213-2600(20)30076-X</pub-id>
<pub-id pub-id-type="pmid">32085846</pub-id>
</element-citation>
</ref>
<ref id="B114-ijms-21-05094">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>H.-Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C.-X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.-C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.-P.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X.-Q.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y.-T.</given-names>
</name>
</person-group>
<article-title>Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients</article-title>
<source/>Cell. Mol. Immunol.
          <year>2020</year>
<volume>17</volume>
<fpage>541</fpage>
<lpage>543</lpage>
<pub-id pub-id-type="doi">10.1038/s41423-020-0401-3</pub-id>
<pub-id pub-id-type="pmid">32203186</pub-id>
</element-citation>
</ref>
<ref id="B115-ijms-21-05094">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Qiao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>X.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients</article-title>
<source/>Cell. Mol. Immunol.
          <year>2020</year>
<volume>17</volume>
<fpage>650</fpage>
<lpage>652</lpage>
<pub-id pub-id-type="doi">10.1038/s41423-020-0447-2</pub-id>
<pub-id pub-id-type="pmid">32346099</pub-id>
</element-citation>
</ref>
<ref id="B116-ijms-21-05094">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)</article-title>
<source/>Front. Immunol.
          <year>2020</year>
<volume>11</volume>
<fpage>827</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2020.00827</pub-id>
<pub-id pub-id-type="pmid">32425950</pub-id>
</element-citation>
</ref>
<ref id="B117-ijms-21-05094">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Omarjee</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Janin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Perrot</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Laviolle</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Meilhac</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Mahe</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19</article-title>
<source/>Clin. Immunol.
          <year>2020</year>
<volume>216</volume>
<fpage>108464</fpage>
<pub-id pub-id-type="doi">10.1016/j.clim.2020.108464</pub-id>
<pub-id pub-id-type="pmid">32405269</pub-id>
</element-citation>
</ref>
<ref id="B118-ijms-21-05094">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mannick</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Del Giudice</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lattanzi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Valiante</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>Praestgaard</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lonetto</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Maecker</surname>
<given-names>H.T.</given-names>
</name>
<name>
<surname>Kovarik</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Carson</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>mTOR inhibition improves immune function in the elderly</article-title>
<source/>Sci. Transl. Med.
          <year>2014</year>
<volume>6</volume>
<fpage>268ra179</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3009892</pub-id>
</element-citation>
</ref>
<ref id="B119-ijms-21-05094">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coperchini</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chiovato</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Croce</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Magri</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rotondi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system</article-title>
<source/>Cytokine Growth Factor Rev.
          <year>2020</year>
<volume>53</volume>
<fpage>25</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1016/j.cytogfr.2020.05.003</pub-id>
<pub-id pub-id-type="pmid">32446778</pub-id>
</element-citation>
</ref>
<ref id="B120-ijms-21-05094">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan</article-title>
<source/>China Lancet
          <year>2020</year>
<volume>395</volume>
<fpage>497</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id>
<pub-id pub-id-type="pmid">31986264</pub-id>
</element-citation>
</ref>
<ref id="B121-ijms-21-05094">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical and immunological features of severe and moderate coronavirus disease 2019</article-title>
<source/>J. Clin. Investig.
          <year>2020</year>
<volume>130</volume>
<fpage>2620</fpage>
<lpage>2629</lpage>
<pub-id pub-id-type="doi">10.1172/JCI137244</pub-id>
<pub-id pub-id-type="pmid">32217835</pub-id>
</element-citation>
</ref>
<ref id="B122-ijms-21-05094">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crespo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Welling</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment</article-title>
<source/>Curr. Opin. Immunol.
          <year>2013</year>
<volume>25</volume>
<fpage>214</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1016/j.coi.2012.12.003</pub-id>
<pub-id pub-id-type="pmid">23298609</pub-id>
</element-citation>
</ref>
<ref id="B123-ijms-21-05094">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>CoppÃ©</surname>
<given-names>J.-P.</given-names>
</name>
<name>
<surname>Desprez</surname>
<given-names>P.-Y.</given-names>
</name>
<name>
<surname>Krtolica</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Campisi</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression</article-title>
<source/>Annu. Rev. Pathol. Mech. Dis.
          <year>2010</year>
<volume>5</volume>
<fpage>99</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-pathol-121808-102144</pub-id>
</element-citation>
</ref>
<ref id="B124-ijms-21-05094">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dock</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Effros</surname>
<given-names>R.B.</given-names>
</name>
</person-group>
<article-title>Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence</article-title>
<source/>Aging Dis.
          <year>2011</year>
<volume>2</volume>
<fpage>382</fpage>
<lpage>397</lpage>
<pub-id pub-id-type="pmid">22308228</pub-id>
</element-citation>
</ref>
<ref id="B125-ijms-21-05094">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cole</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Arevalo</surname>
<given-names>J.M.G.</given-names>
</name>
<name>
<surname>Ruggiero</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Heckman</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Suomi</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>Transcriptional modulation of the developing immune system by early life social adversity</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2012</year>
<volume>109</volume>
<fpage>20578</fpage>
<lpage>20583</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1218253109</pub-id>
<pub-id pub-id-type="pmid">23184974</pub-id>
</element-citation>
</ref>
<ref id="B126-ijms-21-05094">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fok</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nicholls</surname>
<given-names>E.F.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kobor</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2009</year>
<volume>106</volume>
<fpage>14716</fpage>
<lpage>14721</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0902971106</pub-id>
<pub-id pub-id-type="pmid">19617551</pub-id>
</element-citation>
</ref>
<ref id="B127-ijms-21-05094">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sze</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Marin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Arevalo</surname>
<given-names>J.M.G.</given-names>
</name>
<name>
<surname>Doll</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>S.W.</given-names>
</name>
</person-group>
<article-title>A Functional Genomic Fingerprint of Chronic Stress in Humans: Blunted Glucocorticoid and Increased NF-ÎºB Signaling</article-title>
<source/>Boil. Psychiatry
          <year>2008</year>
<volume>64</volume>
<fpage>266</fpage>
<lpage>272</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2008.03.017</pub-id>
<pub-id pub-id-type="pmid">18440494</pub-id>
</element-citation>
</ref>
<ref id="B128-ijms-21-05094">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cole</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Hawkley</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Arevalo</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Cacioppo</surname>
<given-names>J.T.</given-names>
</name>
</person-group>
<article-title>Social regulation of gene expression in human leukocytes</article-title>
<source/>Genome Boil.
          <year>2007</year>
<volume>8</volume>
<fpage>R189</fpage>
<pub-id pub-id-type="doi">10.1186/gb-2007-8-9-r189</pub-id>
</element-citation>
</ref>
<ref id="B129-ijms-21-05094">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>OâDonovan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rempel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lenoci</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pulliam</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Neylan</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Transcriptional control of monocyte gene expression in post-traumatic stress disorder</article-title>
<source/>Dis. Markers
          <year>2011</year>
<volume>30</volume>
<fpage>123</fpage>
<lpage>132</lpage>
<pub-id pub-id-type="doi">10.1155/2011/560572</pub-id>
<pub-id pub-id-type="pmid">21508516</pub-id>
</element-citation>
</ref>
<ref id="B130-ijms-21-05094">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cole</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Hawkley</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Arevalo</surname>
<given-names>J.M.G.</given-names>
</name>
<name>
<surname>Cacioppo</surname>
<given-names>J.T.</given-names>
</name>
</person-group>
<article-title>Transcript origin analysis identifies antigen-presenting cells as primary targets of socially regulated gene expression in leukocytes</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2011</year>
<volume>108</volume>
<fpage>3080</fpage>
<lpage>3085</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1014218108</pub-id>
<pub-id pub-id-type="pmid">21300872</pub-id>
</element-citation>
</ref>
<ref id="B131-ijms-21-05094">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antoni</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Lutgendorf</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Blomberg</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Carver</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Lechner</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Diaz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stagl</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Arevalo</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>S.W.</given-names>
</name>
</person-group>
<article-title>Cognitive-Behavioral Stress Management Reverses Anxiety-Related Leukocyte Transcriptional Dynamics</article-title>
<source/>Boil. Psychiatry
          <year>2012</year>
<volume>71</volume>
<fpage>366</fpage>
<lpage>372</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2011.10.007</pub-id>
</element-citation>
</ref>
<ref id="B132-ijms-21-05094">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Irwin</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>S.W.</given-names>
</name>
</person-group>
<article-title>Reciprocal regulation of the neural and innate immune systems</article-title>
<source/>Nat. Rev. Immunol.
          <year>2011</year>
<volume>11</volume>
<fpage>625</fpage>
<lpage>632</lpage>
<pub-id pub-id-type="doi">10.1038/nri3042</pub-id>
<pub-id pub-id-type="pmid">21818124</pub-id>
</element-citation>
</ref>
<ref id="B133-ijms-21-05094">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>E Miller</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>A Walker</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Arevalo</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>S.W.</given-names>
</name>
</person-group>
<article-title>Genome-wide transcriptional profiling linked to social class in asthma</article-title>
<source/>Thorax
          <year>2008</year>
<volume>64</volume>
<fpage>38</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1136/thx.2007.095091</pub-id>
<pub-id pub-id-type="pmid">19001005</pub-id>
</element-citation>
</ref>
<ref id="B134-ijms-21-05094">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shirtcliff</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Pollak</surname>
<given-names>S.D.</given-names>
</name>
</person-group>
<article-title>Early childhood stress is associated with elevated antibody levels to herpes simplex virus type 1</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2009</year>
<volume>106</volume>
<fpage>2963</fpage>
<lpage>2967</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0806660106</pub-id>
<pub-id pub-id-type="pmid">19188604</pub-id>
</element-citation>
</ref>
<ref id="B135-ijms-21-05094">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sloan</surname>
<given-names>E.K.</given-names>
</name>
<name>
<surname>Capitanio</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Tarara</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Mendoza</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>S.W.</given-names>
</name>
</person-group>
<article-title>Social Stress Enhances Sympathetic Innervation of Primate Lymph Nodes: Mechanisms and Implications for Viral Pathogenesis</article-title>
<source/>J. Neurosci.
          <year>2007</year>
<volume>27</volume>
<fpage>8857</fpage>
<lpage>8865</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1247-07.2007</pub-id>
<pub-id pub-id-type="pmid">17699667</pub-id>
</element-citation>
</ref>
<ref id="B136-ijms-21-05094">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duffy</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>McLaughlin</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Early life adversity and health-risk behaviors: Proposed psychological and neural mechanisms</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>2018</year>
<volume>1428</volume>
<fpage>151</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="doi">10.1111/nyas.13928</pub-id>
<pub-id pub-id-type="pmid">30011075</pub-id>
</element-citation>
</ref>
<ref id="B137-ijms-21-05094">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volkow</surname>
<given-names>N.D.</given-names>
</name>
<name>
<surname>Wise</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>How can drug addiction help us understand obesity?</article-title>
<source/>Nat. Neurosci.
          <year>2005</year>
<volume>8</volume>
<fpage>555</fpage>
<lpage>560</lpage>
<pub-id pub-id-type="doi">10.1038/nn1452</pub-id>
<pub-id pub-id-type="pmid">15856062</pub-id>
</element-citation>
</ref>
<ref id="B138-ijms-21-05094">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guan</surname>
<given-names>W.-J.</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>Z.-Y.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>W.-H.</given-names>
</name>
<name>
<surname>Ou</surname>
<given-names>C.-Q.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.-X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>C.-L.</given-names>
</name>
<name>
<surname>Hui</surname>
<given-names>D.S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical Characteristics of Coronavirus Disease 2019 in China</article-title>
<source/>N. Engl. J. Med.
          <year>2020</year>
<volume>382</volume>
<fpage>1708</fpage>
<lpage>1720</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa2002032</pub-id>
<pub-id pub-id-type="pmid">32109013</pub-id>
</element-citation>
</ref>
<ref id="B139-ijms-21-05094">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Association Between Clinical Manifestations and Prognosis in Patients with COVID-19</article-title>
<source/>Clin. Ther.
          <year>2020</year>
<volume>42</volume>
<fpage>964</fpage>
<lpage>972</lpage>
<pub-id pub-id-type="doi">10.1016/j.clinthera.2020.04.009</pub-id>
<pub-id pub-id-type="pmid">32362344</pub-id>
</element-citation>
</ref>
<ref id="B140-ijms-21-05094">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vardavas</surname>
<given-names>C.I.</given-names>
</name>
<name>
<surname>Nikitara</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>COVID-19 and smoking: A systematic review of the evidence</article-title>
<source/>Tob. Induc. Dis.
          <year>2020</year>
<volume>18</volume>
<fpage>20</fpage>
<pub-id pub-id-type="doi">10.18332/tid/119324</pub-id>
<pub-id pub-id-type="pmid">32206052</pub-id>
</element-citation>
</ref>
<ref id="B141-ijms-21-05094">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lian</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis</article-title>
<source/>J. Med. Virol.
          <year>2020</year>
<pub-id pub-id-type="doi">10.1002/jmv.25889</pub-id>
</element-citation>
</ref>
<ref id="B142-ijms-21-05094">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Risk factors of critical &amp; mortal COVID-19 cases: A systematic literature review and meta-analysis</article-title>
<source/>J. Infect.
          <year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.jinf.2020.04.021</pub-id>
</element-citation>
</ref>
<ref id="B143-ijms-21-05094">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lippi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Henry</surname>
<given-names>B.M.</given-names>
</name>
</person-group>
<article-title>Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)</article-title>
<source/>Eur. J. Intern. Med.
          <year>2020</year>
<volume>75</volume>
<fpage>107</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejim.2020.03.014</pub-id>
<pub-id pub-id-type="pmid">32192856</pub-id>
</element-citation>
</ref>
<ref id="B144-ijms-21-05094">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scully</surname>
<given-names>E.P.</given-names>
</name>
<name>
<surname>Haverfield</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ursin</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Tannenbaum</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>Considering how biological sex impacts immune responses and COVID-19 outcomes</article-title>
<source/>Nat. Rev. Immunol.
          <year>2020</year>
<volume>20</volume>
<fpage>442</fpage>
<lpage>447</lpage>
<pub-id pub-id-type="doi">10.1038/s41577-020-0348-8</pub-id>
<pub-id pub-id-type="pmid">32528136</pub-id>
</element-citation>
</ref>
<ref id="B145-ijms-21-05094">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zaba</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Giresi</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Longmire</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Greenleaf</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H.Y.</given-names>
</name>
</person-group>
<article-title>Individuality and variation of personal regulomes in primary human T cells</article-title>
<source/>Cell Syst.
          <year>2015</year>
<volume>1</volume>
<fpage>51</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1016/j.cels.2015.06.003</pub-id>
<pub-id pub-id-type="pmid">26251845</pub-id>
</element-citation>
</ref>
<ref id="B146-ijms-21-05094">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Syrett</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Atchison</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Anguera</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>Unusual maintenance of X chromosome inactivation predisposes female lymphocytes for increased expression from the inactive X</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2016</year>
<volume>113</volume>
<fpage>E2029</fpage>
<lpage>E2038</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1520113113</pub-id>
<pub-id pub-id-type="pmid">27001848</pub-id>
</element-citation>
</ref>
<ref id="B147-ijms-21-05094">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China</article-title>
<source/>Intensiv. Care Med.
          <year>2020</year>
<volume>46</volume>
<fpage>1294</fpage>
<lpage>1297</lpage>
<pub-id pub-id-type="doi">10.1007/s00134-020-06028-z</pub-id>
<pub-id pub-id-type="pmid">32253449</pub-id>
</element-citation>
</ref>
<ref id="B148-ijms-21-05094">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study</article-title>
<source/>Lancet Respir. Med.
          <year>2020</year>
<volume>8</volume>
<fpage>475</fpage>
<lpage>481</lpage>
<pub-id pub-id-type="doi">10.1016/S2213-2600(20)30079-5</pub-id>
<pub-id pub-id-type="pmid">32105632</pub-id>
</element-citation>
</ref>
<ref id="B149-ijms-21-05094">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azizieh</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>OâAlyahya</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Raghupathy</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Association between levels of vitamin D and inflammatory markers in healthy women</article-title>
<source/>J. Inflamm. Res.
          <year>2016</year>
<volume>9</volume>
<fpage>51</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.2147/JIR.S103298</pub-id>
<pub-id pub-id-type="pmid">27175089</pub-id>
</element-citation>
</ref>
<ref id="B150-ijms-21-05094">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adegoke</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>O.S.</given-names>
</name>
<name>
<surname>Adekile</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Figueiredo</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Relationship between serum 25-hydroxyvitamin D and inflammatory cytokines in paediatric sickle cell disease</article-title>
<source/>Cytokine
          <year>2017</year>
<volume>96</volume>
<fpage>87</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1016/j.cyto.2017.03.010</pub-id>
<pub-id pub-id-type="pmid">28390266</pub-id>
</element-citation>
</ref>
<ref id="B151-ijms-21-05094">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aranow</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Vitamin D and the immune system</article-title>
<source/>J. Investig. Med.
          <year>2011</year>
<volume>59</volume>
<fpage>881</fpage>
<lpage>886</lpage>
<pub-id pub-id-type="doi">10.2310/JIM.0b013e31821b8755</pub-id>
</element-citation>
</ref>
<ref id="B152-ijms-21-05094">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin Gimenez</surname>
<given-names>V.M.</given-names>
</name>
<name>
<surname>Inserra</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tajer</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Inserra</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tajer</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Mariani</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ferder</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Reiter</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Manucha</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment</article-title>
<source/>Life Sci.
          <year>2020</year>
<volume>254</volume>
<fpage>117808</fpage>
<pub-id pub-id-type="doi">10.1016/j.lfs.2020.117808</pub-id>
<pub-id pub-id-type="pmid">32422305</pub-id>
</element-citation>
</ref>
<ref id="B153-ijms-21-05094">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panfili</surname>
<given-names>F.M.</given-names>
</name>
<name>
<surname>Roversi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>DâArgenio</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cappa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fintini</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Possible role of vitamin D in Covid-19 infection in pediatric population</article-title>
<source/>J. Endocrinol. Investig.
          <year>2020</year>
<pub-id pub-id-type="doi">10.1007/s40618-020-01327-0</pub-id>
</element-citation>
</ref>
<ref id="B154-ijms-21-05094">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daneshkhah</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Agrawal</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Eshein</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Subramanian</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Backman</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>The Possible Role of Vitamin D in Suppressing Cytokine Storm and Associated Mortality in COVID-19 Patients</article-title>
<source/>medRxiv
          <year>2020</year>
</element-citation>
</ref>
<ref id="B155-ijms-21-05094">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martineau</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>A Jolliffe</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Aloia</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Bergman</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dubnov-Raz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Esposito</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ganmaa</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>A Ginde</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Goodall</surname>
<given-names>E.C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Vitamin D supplementation to prevent acute respiratory infections: Individual participant data meta-analysis</article-title>
<source/>Health Technol. Assess.
          <year>2019</year>
<volume>23</volume>
<fpage>1</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.3310/hta23020</pub-id>
</element-citation>
</ref>
<ref id="B156-ijms-21-05094">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dofferhoff</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Piscaer</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Schurgers</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Walk</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>van den Ouweland</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Hackeng</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Lux</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Maassen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Karssemeijer</surname>
<given-names>E.G.</given-names>
</name>
<name>
<surname>Wouters</surname>
<given-names>E.F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reduced Vitamin K Status as A Potentially Modifiable Prognostic Risk Factor in COVID-19</article-title>
<source/>Preprints
          <year>2020</year>
<pub-id pub-id-type="doi">10.20944/preprints202004.0457.v1</pub-id>
</element-citation>
</ref>
<ref id="B157-ijms-21-05094">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dancause</surname>
<given-names>K.N.</given-names>
</name>
<name>
<surname>Elgbeili</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Massart</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Szyf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Laplante</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>DNA methylation mediates the impact of exposure to prenatal maternal stress on BMI and central adiposity in children at age 13Â½ years: Project Ice Storm</article-title>
<source/>Epigenetics
          <year>2015</year>
<volume>10</volume>
<fpage>749</fpage>
<lpage>761</lpage>
<pub-id pub-id-type="doi">10.1080/15592294.2015.1063771</pub-id>
<pub-id pub-id-type="pmid">26098974</pub-id>
</element-citation>
</ref>
<ref id="B158-ijms-21-05094">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Massart</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Suderman</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Machnes</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Elgbeili</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Laplante</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Szyf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>DNA Methylation Signatures Triggered by Prenatal Maternal Stress Exposure to a Natural Disaster: Project Ice Storm</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e107653</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0107653</pub-id>
<pub-id pub-id-type="pmid">25238154</pub-id>
</element-citation>
</ref>
<ref id="B159-ijms-21-05094">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veru</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Laplante</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Luheshi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Prenatal maternal stress exposure and immune function in the offspring</article-title>
<source/>Stress
          <year>2014</year>
<volume>17</volume>
<fpage>133</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="doi">10.3109/10253890.2013.876404</pub-id>
<pub-id pub-id-type="pmid">24417382</pub-id>
</element-citation>
</ref>
<ref id="B160-ijms-21-05094">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heijmans</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Tobi</surname>
<given-names>E.W.</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Putter</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Blauw</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Susser</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Slagboom</surname>
<given-names>P.E.</given-names>
</name>
<name>
<surname>Lumey</surname>
<given-names>L.H.</given-names>
</name>
</person-group>
<article-title>Persistent epigenetic differences associated with prenatal exposure to famine in humans</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2008</year>
<volume>105</volume>
<fpage>17046</fpage>
<lpage>17049</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0806560105</pub-id>
<pub-id pub-id-type="pmid">18955703</pub-id>
</element-citation>
</ref>
<ref id="B161-ijms-21-05094">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulz</surname>
<given-names>L.C.</given-names>
</name>
</person-group>
<article-title>The Dutch Hunger Winter and the developmental origins of health and disease</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2010</year>
<volume>107</volume>
<fpage>16757</fpage>
<lpage>16758</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1012911107</pub-id>
<pub-id pub-id-type="pmid">20855592</pub-id>
</element-citation>
</ref>
<ref id="B162-ijms-21-05094">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roseboom</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>De Rooij</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Painter</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>The Dutch famine and its long-term consequences for adult health</article-title>
<source/>Early Hum. Dev.
          <year>2006</year>
<volume>82</volume>
<fpage>485</fpage>
<lpage>491</lpage>
<pub-id pub-id-type="doi">10.1016/j.earlhumdev.2006.07.001</pub-id>
<pub-id pub-id-type="pmid">16876341</pub-id>
</element-citation>
</ref>
<ref id="B163-ijms-21-05094">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Susser</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Neugebauer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hoek</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Labovitz</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gorman</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Schizophrenia after prenatal famine. Further evidence</article-title>
<source/>Arch. Gen. Psychiatry
          <year>1996</year>
<volume>53</volume>
<fpage>25</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.1996.01830010027005</pub-id>
<pub-id pub-id-type="pmid">8540774</pub-id>
</element-citation>
</ref>
<ref id="B164-ijms-21-05094">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tobi</surname>
<given-names>E.W.</given-names>
</name>
<name>
<surname>Lumey</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>Talens</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Kremer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Putter</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Slagboom</surname>
<given-names>P.E.</given-names>
</name>
<name>
<surname>Heijmans</surname>
<given-names>B.T.</given-names>
</name>
</person-group>
<article-title>DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific</article-title>
<source/>Hum. Mol. Genet.
          <year>2009</year>
<volume>18</volume>
<fpage>4046</fpage>
<lpage>4053</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddp353</pub-id>
<pub-id pub-id-type="pmid">19656776</pub-id>
</element-citation>
</ref>
<ref id="B165-ijms-21-05094">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shanes</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Mithal</surname>
<given-names>L.B.</given-names>
</name>
<name>
<surname>Otero</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Azad</surname>
<given-names>H.A.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Placental Pathology in COVID-19</article-title>
<source/>Am. J. Clin. Pathol.
          <year>2020</year>
<volume>154</volume>
<fpage>23</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1093/ajcp/aqaa089</pub-id>
<pub-id pub-id-type="pmid">32441303</pub-id>
</element-citation>
</ref>
<ref id="B166-ijms-21-05094">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>KnÃ¶fler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Haider</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Saleh</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pollheimer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gamage</surname>
<given-names>T.K.J.B.</given-names>
</name>
<name>
<surname>James</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Human placenta and trophoblast development: Key molecular mechanisms and model systems</article-title>
<source/>Cell. Mol. Life Sci.
          <year>2019</year>
<volume>76</volume>
<fpage>3479</fpage>
<lpage>3496</lpage>
<pub-id pub-id-type="doi">10.1007/s00018-019-03104-6</pub-id>
<pub-id pub-id-type="pmid">31049600</pub-id>
</element-citation>
</ref>
<ref id="B167-ijms-21-05094">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mazumder</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Almond</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Crimmins</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Finch</surname>
<given-names>C.E.</given-names>
</name>
</person-group>
<article-title>Lingering prenatal effects of the 1918 influenza pandemic on cardiovascular disease</article-title>
<source/>J. Dev. Orig. Health Dis.
          <year>2009</year>
<volume>1</volume>
<fpage>26</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1017/S2040174409990031</pub-id>
<pub-id pub-id-type="pmid">20198106</pub-id>
</element-citation>
</ref>
<ref id="B168-ijms-21-05094">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turner</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>DâAmbrosio</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>VÃ¶gele</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Diewald</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Twin Research in the Post-Genomic Era: Dissecting the Pathophysiological Effects of Adversity and the Social Environment</article-title>
<source/>Int. J. Mol. Sci.
          <year>2020</year>
<volume>21</volume>
<elocation-id>3142</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms21093142</pub-id>
</element-citation>
</ref>
<ref id="B169-ijms-21-05094">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turner</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Childhood adversity from conception onwards: Are our tools unnecessarily hindering us?</article-title>
<source/>J. Behav. Med.
          <year>2018</year>
<volume>41</volume>
<fpage>568</fpage>
<lpage>570</lpage>
<pub-id pub-id-type="doi">10.1007/s10865-018-9939-2</pub-id>
<pub-id pub-id-type="pmid">29802534</pub-id>
</element-citation>
</ref>
<ref id="B170-ijms-21-05094">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ong</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>The Impact of Anonymity on Responses to Sensitive Questions1</article-title>
<source/>J. Appl. Soc. Psychol.
          <year>2000</year>
<volume>30</volume>
<fpage>1691</fpage>
<lpage>1708</lpage>
<pub-id pub-id-type="doi">10.1111/j.1559-1816.2000.tb02462.x</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="ijms-21-05094-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Immune adaptation mediated by early life adversity. Early-life adversity (ELA) is broken down into its four key components: psychosocial stress, infectious stress, nutrition and the microbiome; and pollutant exposure. They are linked to increases in the numbers of senescent cytotoxic lymphocyte (sCTL) which, upon stimulation are resistant to apoptosis and release large quantities of expression of pro-inflammatory. Certain elements have also been shown to alter the underlying transcriptional identity of leucocytes such as macrophages, dendritic cells or T lymphocytes. This phenomenon is called âthe conserved transcriptional response to adversityâ (CTRA).</p>
</caption>
<graphic xlink:href="ijms-21-05094-g001"></graphic>
</fig>
<fig id="ijms-21-05094-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>The immune reaction to coronavirus disease (COVID-19). The adaptive response to SARS-CoV-2 is a classical anti-viral response. On the right side, once recognized by antigen presenting cell (APC), Th<sub>2</sub> response is activated and induced maturation of B cell. After maturation precursor B cell produces a specific antibody against SARS-cov-2 while mature B cell retain memory of SAR-COV-2 to produce antibodies in case of new infection. Once the Th1 system is activated it induces activation of precursor cytotoxic lymphocyte T (pCTL) due to expression of many cytokines (IL-12, IL2). In one hand, effector (eCTL) can release proteins as granzyme to destroy infected cell in case of mild infection. In case of severe infection, CTL become exhausted (exCTL) and express PD-1, TIGIT and CTLA-4. In patients with having experienced ELA, the increased relative number of sCTL having lost CD28 expression will produce a less efficient lysis of SARS-CoV-2 infected cells. The recognition and clearance by NK cells and the initial role if Interferons is omitted for clarity. Cell images were from <uri xlink:href="http://www.clker.com">http://www.clker.com</uri> with the right to re-use them.</p>
</caption>
<graphic xlink:href="ijms-21-05094-g002"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>